<!DOCTYPE html>
<html lang="en-us">
  <head>
    <meta charset="utf-8">
    <meta name="viewport" content="width=device-width, initial-scale=1">
    
    <title>Posts | Fallingstar Daily R</title>
    <link rel="stylesheet" href="/css/style.css" />
    <link rel="stylesheet" href="/css/fonts.css" />
    <link href="//cdn.bootcss.com/highlight.js/9.12.0/styles/github.min.css" rel="stylesheet">

  </head>

  <body>
    <nav class="header">
      <div class="banner">
<a href="/" class="text">
&Ffr;&Afr;&Lfr;&Lfr;&Ifr;&Nfr;&Gfr;&Sfr;&Tfr;&Afr;&Rfr; &Dfr;&Afr;&Ifr;&Lfr;&Yfr; &Rfr;
</a>
</div>

      <div class="head-meta">
      
        <span>Posts</span>
        <span>2024-07-24</span>
      
      </div>
    </nav>


<div class="container">
<main class="list">

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39044599/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240724183054&amp;v=2.18.0.post9&#43;e462414">The structure of the Î³-TuRC at the microtubule minus end - not just one solution</a></h1>
  <div class="date-author">
    
    <span class="date">2024-07-24</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39044599-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240724183054-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    In cells, microtubules (MTs) assemble from Î±/Î²-tubulin subunits at nucleation sites containing the Î³-tubulin ring complex (Î³-TuRC). Within the Î³-TuRC, exposed Î³-tubulin molecules act as templates for MT assembly by interacting with Î±/Î²-tubulin. The vertebrate Î³-TuRC is scaffolded by Î³-tubulin-interacting proteins GCP2-6 arranged in a specific order. Interestingly, the Î³-tubulin molecules in the Î³-TuRC deviate from the cylindrical geometry of MTs, raising the question of how the Î³-TuRC &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39044796/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240724183054&amp;v=2.18.0.post9&#43;e462414">Virtual cardiovascular magnetic resonance training proves feasible and effective: survey data from international participants of the CMR Academy Berlin, Germany</a></h1>
  <div class="date-author">
    
    <span class="date">2024-07-24</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39044796-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240724183054-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSION: The transition from in-person to online CMR training at the CMR Academy Berlin was successful in maintaining overall satisfaction. However, there is room for improvement in terms of increased interaction, particularly for online participants. Future CMR- and potentially also cardiac computer tomography-courses should consider adopting a hybrid format to accommodate participants' preferences and enhance their learning experience, especially to gain level II competency, whereas level &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39045295/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240724183054&amp;v=2.18.0.post9&#43;e462414">Effective symptom relief through continuous integration of palliative care in advanced renal cell carcinoma patients: comprehensive measurement using the palliative care base assessment</a></h1>
  <div class="date-author">
    
    <span class="date">2024-07-24</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39045295-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240724183054-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSION: Our analysis shows that the integration of palliative care treatment is effective throughout the disease in mRCC and could measurably reduce the symptom burden in our patient population. Palliative care should not be equated with end-of-life care but should rather be integrated throughout advanced disease, particularly as soon as a cure is &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39045550/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240724183054&amp;v=2.18.0.post9&#43;e462414">Baseline monocyte count predicts symptom improvement during intravenous ketamine therapy in treatment-resistant depression: a single-arm open-label observational study</a></h1>
  <div class="date-author">
    
    <span class="date">2024-07-24</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39045550-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240724183054-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSIONS: Our prospective single-arm open-label observational study demonstrated that baseline AMC reliably predicted symptom improvement during intravenous ketamine treatment in TRD patients. AMC could therefore serve as a simple and easily accessible marker for symptom improvement during ketamine therapy in daily clinical practice. Future studies with larger sample sizes and a more detailed longitudinal assessment of AMC subtypes are needed to better understand the specific &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39045626/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240724183054&amp;v=2.18.0.post9&#43;e462414">Synthesis and Development of Inverse-Type Nucleoside Diarylethene Photoswitches</a></h1>
  <div class="date-author">
    
    <span class="date">2024-07-24</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39045626-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240724183054-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Nucleosidic diarylethenes (DAEs) have evolved from an emerging class of photochromes into a well-established option for integrating photochromic functionalities into biological systems. However, a comprehensive understanding of how chemical structure influences their photochromic properties remains essential. While structural features, such as an inverse connection between the aryl residues and the ethene bridge, are well-documented for classical DAEs, their application to nucleosidic DAEs &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39045708/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240724183054&amp;v=2.18.0.post9&#43;e462414">Save the subchondral bone plate: Debridement versus bone marrow stimulation in acetabular cartilage defects over 60 months of follow-up</a></h1>
  <div class="date-author">
    
    <span class="date">2024-07-24</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39045708-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240724183054-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSION: Patients with chondral lesions of the hip â‰¤400 mmÂ² sustainably benefit from arthroscopic debridement under preservation of the subchondral bone plate in terms of functional outcome and pain in contrast to patients treated with bone marrow stimulation. These findings discourage the currently recommended use of microfracture in the hip &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39046150/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240724183054&amp;v=2.18.0.post9&#43;e462414">A prospective evaluation of the diagnostic accuracy of the point-of-care VISITECT CD4 Advanced Disease test in seven countries</a></h1>
  <div class="date-author">
    
    <span class="date">2024-07-24</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39046150-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240724183054-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSIONS: VISITECT&rsquo;s sensitivity, but not specificity, met the World Health Organization&rsquo;s minimal sensitivity and specificity threshold of 80% for point-of-care CD4 tests. VISITECT&rsquo;s quality needs to be assessed and its accuracy optimized. VISITECTÂ´s utility as CD4 triage test should be &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39046157/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1LIK-026Y9bjRE4xDQ231BSa89BnY4O2Rfi-9WXQd8C31C6cqE&amp;fc=20211015124055&amp;ff=20240724182946&amp;v=2.18.0.post9&#43;e462414">Twice-Yearly Lenacapavir or Daily F/TAF for HIV Prevention in Cisgender Women</a></h1>
  <div class="date-author">
    
    <span class="date">2024-07-24</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39046157-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1lik-026y9bjre4xdq231bsa89bny4o2rfi-9wxqd8c31c6cqe-fc-20211015124055-ff-20240724182946-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSIONS: No participants receiving twice-yearly lenacapavir acquired HIV infection. HIV incidence with lenacapavir was significantly lower than background HIV incidence and HIV incidence with F/TDF. (Funded by Gilead Sciences; PURPOSE 1 ClinicalTrials.gov number, &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39046168/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1LIK-026Y9bjRE4xDQ231BSa89BnY4O2Rfi-9WXQd8C31C6cqE&amp;fc=20211015124055&amp;ff=20240724182946&amp;v=2.18.0.post9&#43;e462414">The Real PURPOSE of PrEP - Effectiveness, Not Efficacy</a></h1>
  <div class="date-author">
    
    <span class="date">2024-07-24</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39046168-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1lik-026y9bjre4xdq231bsa89bny4o2rfi-9wxqd8c31c6cqe-fc-20211015124055-ff-20240724182946-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39046178/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240724183054&amp;v=2.18.0.post9&#43;e462414">The free vastus lateralis-And conjoined vastus lateralis anterolateral thigh/tensor fascia lata flap for oncological chest wall reconstruction</a></h1>
  <div class="date-author">
    
    <span class="date">2024-07-24</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39046178-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240724183054-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSION: The free (conjoined) VL flap provides reliable outcomes for obliterating dead space achieving durable reconstruction of complex chest wall &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39046350/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1LIK-026Y9bjRE4xDQ231BSa89BnY4O2Rfi-9WXQd8C31C6cqE&amp;fc=20211015124055&amp;ff=20240724182946&amp;v=2.18.0.post9&#43;e462414">Features of HIV Infection in the Context of Long-Acting Cabotegravir Preexposure Prophylaxis</a></h1>
  <div class="date-author">
    
    <span class="date">2024-07-24</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39046350-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1lik-026y9bjre4xdq231bsa89bny4o2rfi-9wxqd8c31c6cqe-fc-20211015124055-ff-20240724182946-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39046507/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240724183054&amp;v=2.18.0.post9&#43;e462414">Correction to: Persistent sodium currents in neurons: potential mechanisms and pharmacological blockers</a></h1>
  <div class="date-author">
    
    <span class="date">2024-07-24</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39046507-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240724183054-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39046525/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240724183054&amp;v=2.18.0.post9&#43;e462414">Retrospective assessment of ICD-10/DSM-5 criteria of childhood ADHD from descriptions of academic and social behaviors in German primary school reports</a></h1>
  <div class="date-author">
    
    <span class="date">2024-07-24</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39046525-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240724183054-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSIONS: Our findings suggest that systematic quantitative analysis of primary school reports should be further explored to construct a valid instrument for retrospective assessment of childhood ADHD criteria to aid the diagnostic process in adolescents and &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39046537/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240724183054&amp;v=2.18.0.post9&#43;e462414">The long-term learning curve of holmium laser enucleation of the prostate (HoLEP) in the en-bloc technique: a single surgeon series of 500 consecutive cases</a></h1>
  <div class="date-author">
    
    <span class="date">2024-07-24</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39046537-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240724183054-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSIONS: HoLEP using the en-bloc technique is a safe and highly effective method. Over time, a slight but steady learning curve and improvement in operation time, enucleation efficiency and laser energy efficiency were shown even for an experienced surgeon - after 500 cases, still no plateau was reached. There was no measurable learning curve regarding blood loss, complications, length of hospital stay, and catheterization &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39046625/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240724183054&amp;v=2.18.0.post9&#43;e462414">Metabolic and Bariatric Surgeon Criteria-An International Experts&#39; Consensus</a></h1>
  <div class="date-author">
    
    <span class="date">2024-07-24</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39046625-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240724183054-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSION: MBS surgeons should have a degree in general surgery and have been enrolled in a dedicated fellowship training program with a structured curriculum. The learning curve of MBS procedures is procedure dependent. MBS surgeons must demonstrate proficiency in managing postoperative complications, collaborate within a multidisciplinary team, commit to a minimum 2-year patient follow-up, and actively engage in national and international MBS &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39046762/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=journals&amp;utm_content=7603509&amp;fc=None&amp;ff=20240724182556&amp;v=2.18.0.post9&#43;e462414">Critical Role of Tripartite Fusion and LBD Truncation in Certain RARA- and all RARG-Related Atypical APL</a></h1>
  <div class="date-author">
    
    <span class="date">2024-07-24</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39046762-utm-source-curl-utm-medium-rss-utm-campaign-journals-utm-content-7603509-fc-none-ff-20240724182556-v-2-18-0-post9-e462414/">
    
    
    
    
    
      
    
    Atypical acute promyelocytic leukemia (aAPL) presents a complex landscape of retinoic acid receptor (RAR) fusion genes beyond the well-known PML::RARA fusion. Among these, 31 individually rare RARA and RARG fusion genes have been documented, often reported in the canonical X::RAR bipartite fusion form. Intriguingly, some artificially mimicked bipartite X::RAR fusions respond well to all-trans retinoic acid (ATRA) in vitro, contrasting with the ATRA resistance observed in patients. To unravel &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39046767/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=journals&amp;utm_content=7603509&amp;fc=None&amp;ff=20240724182556&amp;v=2.18.0.post9&#43;e462414">Ruxolitinib for pediatric patients with treatment-naÃ¯ve and steroid-refractory acute graft-versus-host disease (REACH4)</a></h1>
  <div class="date-author">
    
    <span class="date">2024-07-24</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39046767-utm-source-curl-utm-medium-rss-utm-campaign-journals-utm-content-7603509-fc-none-ff-20240724182556-v-2-18-0-post9-e462414/">
    
    
    
    
    
      
    
    In REACH4 (NCT03491215), a phase 1/2, open-label, single-arm, multicenter study, the pharmacokinetics (PK), efficacy, and safety of ruxolitinib were evaluated in treatment-naÃ¯ve and steroid-refractory pediatric patients with grade II-IV acute graft-versus-host disease (aGVHD; n=45). Ruxolitinib dosing was based on age and targeted the exposure in adults receiving 10 mg twice daily; group 1 (â‰¥12 to &lt;18 years) received 10 mg twice daily and preliminary starting doses for groups 2 (â‰¥6 to &lt;12 &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39046770/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=journals&amp;utm_content=7603509&amp;fc=None&amp;ff=20240724182556&amp;v=2.18.0.post9&#43;e462414">KDM6A Regulates Immune Response Genes in Multiple Myeloma</a></h1>
  <div class="date-author">
    
    <span class="date">2024-07-24</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39046770-utm-source-curl-utm-medium-rss-utm-campaign-journals-utm-content-7603509-fc-none-ff-20240724182556-v-2-18-0-post9-e462414/">
    
    
    
    
    
      
    
    The histone H3K27 demethylase KDM6A is a tumor suppressor in multiple cancers, including multiple myeloma (MM). We created isogenic MM cells disrupted for KDM6A and tagged the endogenous protein to facilitate genome wide studies. KDM6A binds genes associated with immune recognition and cytokine signaling. Most importantly, KDM6A binds and activates NLRC5 and CIITA encoding regulators of Major Histocompatibility Complex (MHC) genes. Patient data indicate that NLRC5 and CIITA, are downregulated &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39046779/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=journals&amp;utm_content=7603509&amp;fc=None&amp;ff=20240724182556&amp;v=2.18.0.post9&#43;e462414">Diagnostic Guidelines for Familial Hemophagocytic Lymphohistiocytosis Revisited</a></h1>
  <div class="date-author">
    
    <span class="date">2024-07-24</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39046779-utm-source-curl-utm-medium-rss-utm-campaign-journals-utm-content-7603509-fc-none-ff-20240724182556-v-2-18-0-post9-e462414/">
    
    
    
    
    
      
    
    Current HLH-2004-based diagnostic criteria for familial hemophagocytic lymphohistiocytosis (FHL) are based on expert opinion. Here we performed a case-control study to test and possibly improve these clinical criteria. We also developed two complementary expert opinion-based diagnostic strategies for FHL in patients with signs/symptoms suggestive of HLH, based on genetic and cellular cytotoxicity assays. The cases (n=366) were children &lt;16 years with verified familial and/or genetic FHL &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39046783/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=journals&amp;utm_content=7603509&amp;fc=None&amp;ff=20240724182556&amp;v=2.18.0.post9&#43;e462414">JAK2/mTOR Inhibition Fails to Prevent Acute GVHD Despite Reduced Th1/Th17 cells: Final Phase II Trial Results</a></h1>
  <div class="date-author">
    
    <span class="date">2024-07-24</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39046783-utm-source-curl-utm-medium-rss-utm-campaign-journals-utm-content-7603509-fc-none-ff-20240724182556-v-2-18-0-post9-e462414/">
    
    
    
    
    
      
    
    Our phase I graft-versus-host disease (GVHD) prevention trial of JAK2 inhibitor, pacritinib, (recommended phase II dose: 100mg po BID day 0 to +70) plus sirolimus and tacrolimus (PAC/SIR/TAC) demonstrated the regimen was safe and free of pan-JAK myelosuppression after allogeneic hematopoietic cell transplantation (alloHCT). PAC inhibits IL-6 receptor activity and pathogenic Th1/Th17 differentiation in preclinical models and the phase I trial. Herein we report on our completed phase II trial &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39046786/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=journals&amp;utm_content=7603509&amp;fc=None&amp;ff=20240724182556&amp;v=2.18.0.post9&#43;e462414">A predictive model for therapy failure in chronic myeloid leukemia patients receiving tyrosine kinase inhibitor therapy</a></h1>
  <div class="date-author">
    
    <span class="date">2024-07-24</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39046786-utm-source-curl-utm-medium-rss-utm-campaign-journals-utm-content-7603509-fc-none-ff-20240724182556-v-2-18-0-post9-e462414/">
    
    
    
    
    
      
    
    Although tyrosine kinase inhibitor (TKI) therapy has markedly improved the survival of people with chronic-phase chronic myeloid leukemia (CML), 20-30% of people still experienced therapy failure. Data from 1,955 consecutive subjects with chronic-phase CML diagnosed by the European LeukemiaNet (ELN) recommendations from 1 center receiving initial TKI imatinib or a second-generation (2G-) TKI therapy were interrogated to develop a clinical prediction model for TKI therapy failure. This model &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1251560221/Op1M0b3U3">æˆ‘æƒ³é€šè¿‡ä¸ªäººç»å†ï¼Œè®²è®²ä»€ä¹ˆæ˜¯ä¸€äº›ç°ä»£ç¤¾ä¼šçš„â€œæ”¿æ²»æ­£ç¡®ï¼ˆæ‰€è°“çš„DEI - Diversity/Equity/Inclusionï¼‰â€œï¼Œä¸ºä»€ä¹ˆä¸­æ–‡è¯­è¨€åœˆå¯¹è¿™äº›ç°ä»£ç¤¾ä¼šæ¦‚å¿µè¯¯è§£å¾ˆæ·±ã€‚æˆ‘æƒ³é€šè¿‡...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-07-24</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1251560221-op1m0b3u3/">
    
    
    
    
    
      
    
    æˆ‘æƒ³é€šè¿‡ä¸ªäººç»å†ï¼Œè®²è®²ä»€ä¹ˆæ˜¯ä¸€äº›ç°ä»£ç¤¾ä¼šçš„â€œæ”¿æ²»æ­£ç¡®ï¼ˆæ‰€è°“çš„DEI - Diversity/Equity/Inclusionï¼‰â€œï¼Œä¸ºä»€ä¹ˆä¸­æ–‡è¯­è¨€åœˆå¯¹è¿™äº›ç°ä»£ç¤¾ä¼šæ¦‚å¿µè¯¯è§£å¾ˆæ·±ã€‚æˆ‘æƒ³é€šè¿‡å‡ ä¸ªäº²èº«ç»å†çš„å°æ•…äº‹ï¼Œè®²è®²DEIåˆ°åº•åœ¨ä¿æŠ¤è°ã€‚<!-- raw HTML omitted --><!-- raw HTML omitted -->æˆ‘ä¹‹å‰æœ‰ä¸€ä¸ªåŒäº‹å’Œå¥½å‹ï¼Œæ˜¯ä¸€ä¸ªæ¥è‡ªè·¯æ˜“æ–¯å®‰é‚£å·ï¼ˆLAï¼‰çš„éè£”ç¾å›½äººï¼Œå¥¹éå¸¸èªæ˜åˆ»è‹¦ï¼Œå‡ ä¹å…¨é è‡ªå­¦ï¼Œä»LAè¥¿åŒ—éƒ¨åè¿œå°é•‡è¯»äº†å¤§å­¦ï¼Œåˆä½œä¸ºå•èº«æ¯äº²å¸¦ç€å­©å­è¯»äº†åšå£«ï¼ˆPhDï¼‰ã€‚å¥¹çš„å„¿å­åœ¨DCéƒŠåŒºä¸€ä¸ªéå¸¸å¥½çš„å¤§å­¦è¯»æœ¬ç§‘ï¼Œä½†æ˜¯å¥¹ä»æ¥ä¸æ”¾å¿ƒå„¿å­åœ¨æ™šä¸Šå‡ºé—¨å‚åŠ èšä¼šï¼Œå› ä¸ºæ¯æ¬¡å„¿å­ç¦»å¼€å®¶ï¼Œå¥¹æ‹…å¿ƒå„¿å­å¯èƒ½ä¼šåœ¨ä¸€ä¸ªstop signï¼ˆåœè½¦æ ‡å¿—ï¼‰è¢«è­¦å¯Ÿæ‹¦ä¸‹ï¼Œç„¶åå°±å†ä¹Ÿå›ä¸äº†å®¶ã€‚è¿™ç§äº‹ä»¶æ¯”æ¯”çš†æ˜¯ã€‚å¦‚æœä½ æ˜¯ä¸ªæ¯äº²ï¼Œæ¯æ¬¡å­©å­å‡ºå®¶é—¨ä½ éƒ½å¿§å¿ƒå¿¡å¿¡ï¼Œé‚£ä¹ˆä½ ä¸€å®šä¼šç†è§£ä½œä¸ºä¸€ä¸ªé»‘äººæ¯äº²åœ¨ç¾å›½çš„ç„¦è™‘ã€‚éè£”åœ¨ç¾å›½é•¿æœŸå—åˆ°äº†æä¸ºä¸å…¬çš„å¾…é‡ï¼Œæˆ‘æ¨èæœ‰æ—¶ &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/Op5SDfbig">ğŸ”»èŠ±è²ã€‚ğŸ”»via zoom.earth#å°é£è·¯å¾„# åŒ…å®¹ä¸‡ç‰©æ’æ²³æ°´çš„å¾®åšè§†é¢‘</a></h1>
  <div class="date-author">
    
    <span class="date">2024-07-24</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-op5sdfbig/">
    
    
    
    
    
      
    
    ğŸ”»èŠ±è²ã€‚<!-- raw HTML omitted -->ğŸ”»via zoom.earth<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->#å°é£è·¯å¾„#<!-- raw HTML omitted --><!-- raw HTML omitted --> <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->åŒ…å®¹ä¸‡ç‰©æ’æ²³æ°´çš„å¾®åšè§†é¢‘<!-- raw HTML omitted --><!-- raw HTML omitted --> <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;video &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/Op5Ui9w1w">ğŸ”»æ ¼ç¾è¿˜åœ¨å°æ¹¾ä¸œæµ·å²¸ç»•åœˆã€‚#å°é£è·¯å¾„# [å›¾ç‰‡][å›¾ç‰‡]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-07-24</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-op5ui9w1w/">
    
    
    
    
    
      
    
    ğŸ”»æ ¼ç¾è¿˜åœ¨å°æ¹¾ä¸œæµ·å²¸ç»•åœˆã€‚<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->#å°é£è·¯å¾„#<!-- raw HTML omitted --><!-- raw HTML omitted --> <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;video controls=&ldquo;controls&rdquo; poster=&ldquo;<a href="https://tvax3.sinaimg.cn/orj480/639b1bfbly1hrzk5k7fetj20k00k">https://tvax3.sinaimg.cn/orj480/639b1bfbly1hrzk5k7fetj20k00k</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/Op5VUjKzD">ä¹ - è½¬å‘ @ä¸“ä¸šæˆ³è½®èƒç†Šå¾‹å¸ˆ:&amp;ensp;æˆ‘å¯¹è¿™å‡ å¤©éª—ä¸»ä»»çš„ä¸€äº›æƒ³æ³•ï¼Œè¿˜æ˜¯åšæ³•ï¼Œæå‡ºç‚¹æˆ‘çš„æƒ³æ³•ã€‚æˆ‘ä¹ŸçŸ¥é“æœ‰ä¸å°‘å®£ä¼ å£çš„æœ‹å‹å…³æ³¨ç€â€¦â€¦å…ˆè¯´ç»“è®ºï¼Œæˆ‘çš„è®¤çŸ¥æ˜¯ï¼šä»–è§’...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-07-24</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-op5vujkzd/">
    
    
    
    
    
      
    
    ä¹<!-- raw HTML omitted --><!-- raw HTML omitted --> - è½¬å‘ <!-- raw HTML omitted -->@ä¸“ä¸šæˆ³è½®èƒç†Šå¾‹å¸ˆ<!-- raw HTML omitted -->:â€‚æˆ‘å¯¹è¿™å‡ å¤©éª—ä¸»ä»»çš„ä¸€äº›æƒ³æ³•ï¼Œè¿˜æ˜¯åšæ³•ï¼Œæå‡ºç‚¹æˆ‘çš„æƒ³æ³•ã€‚<!-- raw HTML omitted -->æˆ‘ä¹ŸçŸ¥é“æœ‰ä¸å°‘å®£ä¼ å£çš„æœ‹å‹å…³æ³¨ç€â€¦â€¦<!-- raw HTML omitted -->å…ˆè¯´ç»“è®ºï¼Œæˆ‘çš„è®¤çŸ¥æ˜¯ï¼š<!-- raw HTML omitted -->ä»–è§’è‰²é”™ä½â€¦â€¦<!-- raw HTML omitted -->æœ¬èº«æ¥è¯´ï¼Œå›½å¤–CNNBBSä¹‹ç±»ï¼Œå†åŠ ä¸Šå·æ™®é’¦ç‚¹çš„çº½çº¦æ—¶æŠ¥ï¼Œéƒ½æ˜¯å„ç§é€ è°£ã€‚<!-- raw HTML omitted -->ä»–ä»¬æ¯å¤©å˜ç€æ–°èŠ±æ ·æœ‰å„ç§æ–°è°£è¨€ã€‚<!-- raw HTML omitted -->ç„¶ååŠ ä¸Š1450ä¸€é¡¿æ‰©æ•£ã€‚<!-- raw HTML omitted -->ç®€ä¸­åœˆå†…ä¸€ç›´å¤„åœ¨è¢«åŠ¨æŒ¨æ‰“ï¼Œæ— é™è‡ªè¯å¾ªç¯ã€‚ç¨æœ‰ç‚¹é£å¹è‰åŠ¨ï¼Œå°±æ˜¯èµ›åšäº¡å›½ã€‚<!-- raw HTML omitted -->~<!-- raw HTML omitted -->è€Œè€ä¸­çš„å®˜åª’å‘¢ï¼Œæœ‰é“å¾·åŒ…è¢±ï¼Œä¸èƒ½é€ è°£ã€‚<!-- raw HTML omitted -->è¿™ä¸ªæˆ‘è§‰å¾—OKï¼Œæˆ‘è‡ªå·±ä¹Ÿç®—æ˜¯å®˜åª’å‡ºæ¥çš„ï¼Œä¸‰æ ¡ä¸‰ &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/Op65I53jP">ğŸ”»çœ‹èµ·æ¥ï¼Œæ ¼ç¾åœ¨ç¬¬äºŒæ¬¡å°è¯•ç™»é™†å‰åšäº†ä¸€ä¸ªå®Œæ•´çš„å—åŒ—ç¯æµã€‚ğŸ”»ç°åœ¨åº”è¯¥åœ¨å®œå…°æˆåŠŸç™»é™†äº†ã€‚#å°é£æ ¼ç¾ç›´è§’æ‰å¤´äº†# [å›¾ç‰‡][å›¾ç‰‡][å›¾ç‰‡][å›¾ç‰‡][å›¾ç‰‡][å›¾ç‰‡][å›¾ç‰‡...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-07-24</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-op65i53jp/">
    
    
    
    
    
      
    
    ğŸ”»çœ‹èµ·æ¥ï¼Œæ ¼ç¾åœ¨ç¬¬äºŒæ¬¡å°è¯•ç™»é™†å‰åšäº†ä¸€ä¸ªå®Œæ•´çš„å—åŒ—ç¯æµã€‚<!-- raw HTML omitted -->ğŸ”»ç°åœ¨åº”è¯¥åœ¨å®œå…°æˆåŠŸç™»é™†äº†ã€‚<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->#å°é£æ ¼ç¾ç›´è§’æ‰å¤´äº†#<!-- raw HTML omitted --><!-- raw HTML omitted --> <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;img style=&quot;&quot; src=&ldquo;<a href="https://tvax4.sinaimg.cn/large/639b1bfbly1hrzkxea8swj20l40l4w">https://tvax4.sinaimg.cn/large/639b1bfbly1hrzkxea8swj20l40l4w</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/Op6fG7rc5">æ°‘ç§‘é£ç¬‘ç¬‘å¾—äº†ï¼Œä»€ä¹ˆå«è¥¿æ–¹ç¬¬ä¸€æ¬¡å‘ç°çš„é©¬è½¦æ˜¯äºŒä¸–çºªçš„ã€‚çº½çº¦å¤§éƒ½ä¼šåšç‰©é¦†æœ€è‘—åçš„è—å“ä¹‹ä¸€â€œè’™ç‰¹è±æ˜‚å†…çš„ä¼Šç‰¹é²é‡Œäºšæˆ˜è½¦â€éƒ½ä¸çŸ¥é“ï¼Ÿå…¬å…ƒå‰ 6 ä¸–çºªä¸­å¶çš„ã€‚å¤š...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-07-24</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-op6fg7rc5/">
    
    
    
    
    
      
    
    æ°‘ç§‘é£ç¬‘ç¬‘å¾—äº†ï¼Œä»€ä¹ˆå«è¥¿æ–¹ç¬¬ä¸€æ¬¡å‘ç°çš„é©¬è½¦æ˜¯äºŒä¸–çºªçš„ã€‚çº½çº¦å¤§éƒ½ä¼šåšç‰©é¦†æœ€è‘—åçš„è—å“ä¹‹ä¸€â€œè’™ç‰¹è±æ˜‚å†…çš„ä¼Šç‰¹é²é‡Œäºšæˆ˜è½¦â€éƒ½ä¸çŸ¥é“ï¼Ÿå…¬å…ƒå‰ 6 ä¸–çºªä¸­å¶çš„ã€‚å¤šçœ‹å‡ æœ¬è€ƒå¤æŠ¥å‘Šæ¯”ä»€ä¹ˆéƒ½å¼ºï¼Œæœ‰äº›è¿˜æ˜¯æˆ‘ä»¬çš„è€ƒå¤é˜Ÿè”åˆå‚ä¸çš„ã€‚ <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->è¯„è®ºé…å›¾<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> - è½¬å‘ &lt;a href=&ldquo;<a href="https://weibo.com/2139949234%22">https://weibo.com/2139949234&quot;</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/Op6HmD7fP">ğŸ”»2024å¹´å·´é»å¥¥è¿ç”·è¶³å°ç»„èµ›Bç»„ç¬¬1è½®ï¼ŒU23é˜¿æ ¹å»·1-2ä¸æ•Œæ‘©æ´›å“¥U23ã€‚ğŸ”»æ¯”èµ›å› çƒè¿·æŠ•æ·æ‚ç‰©å¹¶é—¯å…¥åœºå†…ä¸­æ–­ 2 å°æ—¶åï¼Œé˜¿æ ¹å»·é˜Ÿåœ¨ç¬¬ 90&#39;&#43;16 åˆ†é’Ÿæ‰³å¹³æ‘©æ´›å“¥é˜Ÿçš„...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-07-24</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-op6hmd7fp/">
    
    
    
    
    
      
    
    ğŸ”»2024å¹´å·´é»å¥¥è¿ç”·è¶³å°ç»„èµ›Bç»„ç¬¬1è½®ï¼ŒU23é˜¿æ ¹å»·1-2ä¸æ•Œæ‘©æ´›å“¥U23ã€‚<!-- raw HTML omitted -->ğŸ”»æ¯”èµ›å› çƒè¿·æŠ•æ·æ‚ç‰©å¹¶é—¯å…¥åœºå†…ä¸­æ–­ 2 å°æ—¶åï¼Œé˜¿æ ¹å»·é˜Ÿåœ¨ç¬¬ 90'+16 åˆ†é’Ÿæ‰³å¹³æ‘©æ´›å“¥é˜Ÿçš„è¿›çƒå› è¶Šä½åœ¨å…ˆè€Œè¢«åˆ¤æ— æ•ˆã€‚<!-- raw HTML omitted -->ğŸ”»è¿™ä¹ˆæŠ½è±¡çš„å‰§æƒ…å—ï¼Ÿå·´é»å¥¥è¿ä¼šå¼€äº†ä¸ªå¥½å±€å•Šâ€¦â€¦ <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/Op6VNodjs">ğŸ”»â€œä»–ä¸€ç‚¹ä¹Ÿä¸åœ¨ä¹ ğŸ˜­ â€ åŒ…å®¹ä¸‡ç‰©æ’æ²³æ°´çš„å¾®åšè§†é¢‘</a></h1>
  <div class="date-author">
    
    <span class="date">2024-07-24</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-op6vnodjs/">
    
    
    
    
    
      
    
    ğŸ”»â€œä»–ä¸€ç‚¹ä¹Ÿä¸åœ¨ä¹ ğŸ˜­ â€ <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->åŒ…å®¹ä¸‡ç‰©æ’æ²³æ°´çš„å¾®åšè§†é¢‘<!-- raw HTML omitted --><!-- raw HTML omitted --> <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;source src=&ldquo;<a href="https://f.video.weibocdn.com/o0/g6qkfwJdlx08gGAtukQU010412005IHt0E010.mp4?">https://f.video.weibocdn.com/o0/g6qkfwJdlx08gGAtukQU010412005IHt0E010.mp4?</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/Op6vz7H10">ğŸ”»å°æ¹¾å²›æ´»ç”Ÿç”ŸæŠŠæ ¼ç¾ä»è¶…å¼ºå°é£è€—æˆäº†å¼ºå°é£ã€‚ğŸ”»æ™šå®‰ã€‚#å°é£æ ¼ç¾ç›´è§’æ‰å¤´äº†# [å›¾ç‰‡][å›¾ç‰‡][å›¾ç‰‡]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-07-24</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-op6vz7h10/">
    
    
    
    
    
      
    
    ğŸ”»å°æ¹¾å²›æ´»ç”Ÿç”ŸæŠŠæ ¼ç¾ä»è¶…å¼ºå°é£è€—æˆäº†å¼ºå°é£ã€‚<!-- raw HTML omitted -->ğŸ”»æ™šå®‰ã€‚<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->#å°é£æ ¼ç¾ç›´è§’æ‰å¤´äº†#<!-- raw HTML omitted --><!-- raw HTML omitted --> <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;img style=&quot;&quot; src=&ldquo;<a href="https://tvax1.sinaimg.cn/large/639b1bfbly1hrzmj0ccmgj217v10n4qp.jpg">https://tvax1.sinaimg.cn/large/639b1bfbly1hrzmj0ccmgj217v10n4qp.jpg</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/Op75d6NQ3">ğŸ”»å†…å¡”å°¼äºšèƒ¡ä¸€å¼ å˜´ï¼Œå°±æ˜¯è¦æ‹‰ç€ç¾å›½ä¸€èµ·å»å¹²ä¼Šæœ—â€¦â€¦ğŸ”»ä¼Šæœ—æ–°æ€»ç»Ÿï¼š[å¤±æœ›]ğŸ”»ç¾å›½çš„è®®å‘˜ä»¬æ‹¼å‘½é¼“æŒï¼Œç¾å›½äººæ°‘çœŸæœ‰ç¦æ°”ï¼Œç¾å›½çš„è½¯ç¡¬å®åŠ›è¿˜å¤ŸåŒæ—¶é™·å…¥å‡ ä¸ªæ³¥...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-07-24</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-op75d6nq3/">
    
    
    
    
    
      
    
    ğŸ”»å†…å¡”å°¼äºšèƒ¡ä¸€å¼ å˜´ï¼Œå°±æ˜¯è¦æ‹‰ç€ç¾å›½ä¸€èµ·å»å¹²ä¼Šæœ—â€¦â€¦<!-- raw HTML omitted -->ğŸ”»ä¼Šæœ—æ–°æ€»ç»Ÿï¼š<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->ğŸ”»ç¾å›½çš„è®®å‘˜ä»¬æ‹¼å‘½é¼“æŒï¼Œç¾å›½äººæ°‘çœŸæœ‰ç¦æ°”ï¼Œç¾å›½çš„è½¯ç¡¬å®åŠ›è¿˜å¤ŸåŒæ—¶é™·å…¥å‡ ä¸ªæ³¥æ½­å•Šï¼Ÿé™·åœ¨ä¸­ä¸œæ„å‘³ç€ç¾å›½åªèƒ½æ”¾å¼ƒæ¬§æ´²å’Œäºšå¤ªå•Šã€‚<!-- raw HTML omitted -->ğŸ”»â€œæ¯”æ¯”å°±æ˜¯ç¾å›½çš„karmaâ€<!-- raw HTML omitted -->ğŸ”»via C-SPAN <!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;img style=&ldquo;width: 1rem;height: 1rem&rdquo; src=&ldquo;<a href="https://h5.sinaimg.cn/upload/2015/09/25/3/timeline_card_small_video_default.png%22">https://h5.sinaimg.cn/upload/2015/09/25/3/timeline_card_small_video_default.png&quot;</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/3825863518/Op26P1raV">æƒŠé—»æ—åœ¨èŒƒå…ˆç”Ÿå»ä¸–ğŸ•¯ï¸ [å›¾ç‰‡]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-07-24</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-3825863518-op26p1rav/">
    
    
    
    
    
      
    
    æƒŠé—»æ—åœ¨èŒƒå…ˆç”Ÿå»ä¸–ğŸ•¯ï¸ <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/3825863518/Op2SXkBQK">ç¿Šè¿™ä¸ªå­—ä¸å¥½æ‰¾ï¼Œæˆ‘æ‰“å­—çš„æ—¶å€™æŒ‰éƒ¨é¦–æ‰¾ï¼Œç»“æœâ€œç«‹â€å­—æ—é‡Œæ²¡æœ‰ã€‚ä»”ç»†ä¸€æƒ³ï¼Œæœ‰é“ç†ï¼Œç¡®å®æ˜¯â€œç¾½â€å­—æ—[æ€’]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-07-24</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-3825863518-op2sxkbqk/">
    
    
    
    
    
      
    
    ç¿Šè¿™ä¸ªå­—ä¸å¥½æ‰¾ï¼Œæˆ‘æ‰“å­—çš„æ—¶å€™æŒ‰éƒ¨é¦–æ‰¾ï¼Œç»“æœâ€œç«‹â€å­—æ—é‡Œæ²¡æœ‰ã€‚<!-- raw HTML omitted -->ä»”ç»†ä¸€æƒ³ï¼Œæœ‰é“ç†ï¼Œç¡®å®æ˜¯â€œç¾½â€å­—æ—<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->  &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5878312122/Op0pdDfaD">æˆ‘æ²¡æ˜ç™½ä¸ºä»€ä¹ˆå¾ˆå¤šäººæŠŠè¿™ä¸€æ¬¡ä¸€åŠ›è¾½çš„äº‹æƒ…å’Œè€èµµçš„è½®æ¤…å¯¹å±€ç›¸æå¹¶è®ºï¼Œæå˜ã€‚å…ˆæææ¸…æ¥šé‚£æ˜¯38å¹´å‰ï¼Œç°åœ¨å·²ç»2024å¹´äº†ã€‚äººå®¶ä¹Ÿåœ¨è¿›æ­¥ï¼Œåæ®µæˆ˜ç–«æƒ…æé»„äº†ï¼Œå»å¹´é˜¿...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-07-24</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5878312122-op0pddfad/">
    
    
    
    
    
      
    
    æˆ‘æ²¡æ˜ç™½ä¸ºä»€ä¹ˆå¾ˆå¤šäººæŠŠè¿™ä¸€æ¬¡ä¸€åŠ›è¾½çš„äº‹æƒ…å’Œè€èµµçš„è½®æ¤…å¯¹å±€ç›¸æå¹¶è®ºï¼Œæå˜ã€‚<!-- raw HTML omitted --><!-- raw HTML omitted -->å…ˆæææ¸…æ¥šé‚£æ˜¯38å¹´å‰ï¼Œç°åœ¨å·²ç»2024å¹´äº†ã€‚äººå®¶ä¹Ÿåœ¨è¿›æ­¥ï¼Œåæ®µæˆ˜ç–«æƒ…æé»„äº†ï¼Œå»å¹´é˜¿å«æ¡å±±æ¯ä¿©äººéƒ½é˜³äº†ä¹Ÿæ²¡åˆ¤ä¿©äººåŒè´Ÿå•Šã€‚<!-- raw HTML omitted -->å…¶æ¬¡è€èµµå¦‚æœé‚£å¤©åŠå¤œè‚šå­ä¸é¥¿çš„è¯ä¹Ÿä¸ä¼šå‘ç”Ÿé‚£ç§äº‹æƒ…ï¼Œå¦‚æœç›¸æå¹¶è®ºå°±æ˜¯â€œæ´»è¯¥ä¸€åŠ›è¾½è¿›å†³èµ›â€ï¼Œè¿˜æ˜¯è¾“ç»™ä»–çš„éƒ½ä¸äº‰æ°”å¯¼è‡´çš„ã€‚æˆ‘ä¸€åŠ›è¾½å°±ä¸‹ä¸ªæ£‹é”™å“ªäº†ï¼Ÿ<!-- raw HTML omitted -->å†æä¸€ä¸ªä¸è¯¥è¯´çš„ï¼Œäººå®¶è¯»å–å¯¹ä¸­å›½æ˜¯æ€ä¹ˆæƒ³æ³•ï¼Œæœæ—¥å¯¹ä¸­å›½æ˜¯ä»€ä¹ˆæƒ³æ³•ï¼Œæˆ‘ç›¸ä¿¡ä½ ä»¬çš„è§£è¯»æ¯”æˆ‘è¦æ·±åˆ»ã€‚<!-- raw HTML omitted --><!-- raw HTML omitted -->æœ€å·®çš„ç»“æœå°±æ˜¯ä¸€åŠ›è¾½æ¥å—â€œæ´»è¯¥è¿›å†³èµ›â€çš„äº‹å®ï¼Œä¸ä¸‹ç¬¬5å±€äº†ï¼Œä¹Ÿæ˜¯åŠæ³•ã€‚<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->#å›´æ£‹#<!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;a &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5878312122/Op1647Ttw">çœ‹åˆ°æ£‹é“webçš„è¿™å¼ å›¾ï¼Œæˆ‘ç¬¬ä¸€ä¸ªæƒ³åˆ°çš„ç«Ÿç„¶æ˜¯ä¸Šé‡ï¼ˆå§ï¼‰çš„è£¤è¢œå¥½åƒå’Œæˆ‘åŒæ¬¾#å›´æ£‹#å›´æ£‹ [å›¾ç‰‡]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-07-24</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5878312122-op1647ttw/">
    
    
    
    
    
      
    
    çœ‹åˆ°æ£‹é“webçš„è¿™å¼ å›¾ï¼Œæˆ‘ç¬¬ä¸€ä¸ªæƒ³åˆ°çš„ç«Ÿç„¶æ˜¯<!-- raw HTML omitted --><!-- raw HTML omitted -->ä¸Šé‡ï¼ˆå§ï¼‰çš„è£¤è¢œå¥½åƒå’Œæˆ‘åŒæ¬¾<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->#å›´æ£‹#<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->å›´æ£‹&lt;/ &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5878312122/Op1naxpXO">æ£‹æ‰‹æˆ˜é¹°å…«å®šç‹æƒœè´¥æ‹”ç½ç‹ [å›¾ç‰‡][å›¾ç‰‡]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-07-24</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5878312122-op1naxpxo/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->æ£‹æ‰‹æˆ˜é¹°<!-- raw HTML omitted --><!-- raw HTML omitted -->å…«å®šç‹æƒœè´¥æ‹”ç½ç‹ <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;img style=&quot;&quot; src=&ldquo;<a href="https://tvax3.sinaimg.cn/large/006pONvQgy1hrz04y37arj307y09">https://tvax3.sinaimg.cn/large/006pONvQgy1hrz04y37arj307y09</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5878312122/Op2SKbJ2A">éŸ©å›½æ£‹é™¢åˆšåˆšå…¬å¸ƒäº†ä¸‰æ˜Ÿæ¯çš„ç»¼åˆé¢„é€‰å¯¹é˜µè¡¨æˆ‘æŠŠå¤§è¡¨åˆ†æˆäº†å‡ å¼ å°å›¾ï¼Œå¤§å®¶å¯ä»¥çœ‹ä¸€ä¸‹ã€‚#å›´æ£‹#å›´æ£‹ [å›¾ç‰‡][å›¾ç‰‡][å›¾ç‰‡][å›¾ç‰‡][å›¾ç‰‡][å›¾ç‰‡]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-07-24</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5878312122-op2skbj2a/">
    
    
    
    
    
      
    
    éŸ©å›½æ£‹é™¢åˆšåˆšå…¬å¸ƒäº†ä¸‰æ˜Ÿæ¯çš„ç»¼åˆé¢„é€‰å¯¹é˜µè¡¨<!-- raw HTML omitted --><!-- raw HTML omitted -->æˆ‘æŠŠå¤§è¡¨åˆ†æˆäº†å‡ å¼ å°å›¾ï¼Œå¤§å®¶å¯ä»¥çœ‹ä¸€ä¸‹ã€‚<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->#å›´æ£‹#<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->å›´æ£‹<!-- raw HTML omitted -->&lt; &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5878312122/Op35bhYhk">åœ¨æ¨ä¸Šé¢é‡Œèœç»™æˆ‘å‘ç§ä¿¡æŠŠæˆ‘å“äº†ä¸€è·³#å›´æ£‹#å›´æ£‹</a></h1>
  <div class="date-author">
    
    <span class="date">2024-07-24</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5878312122-op35bhyhk/">
    
    
    
    
    
      
    
    åœ¨æ¨ä¸Šé¢é‡Œèœç»™æˆ‘å‘ç§ä¿¡æŠŠæˆ‘å“äº†ä¸€è·³<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->#å›´æ£‹#<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->å›´æ£‹<!-- raw HTML omitted --><!-- raw HTML omitted -->  &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5878312122/Op3fRtKhY">#å¥¥è¿ä¼š# #å·´é»å¥¥è¿ä¼š# - è½¬å‘ @æ£‹æ‰‹æˆ˜é¹°:&amp;ensp;å·´é»å¥¥è¿ä¼šå³å°†åˆ°æ¥ï¼Œé¢„ç¥ä¸­å›½å¥¥è¿å¥å„¿ä»¬å‡¯æ—‹å½’æ¥ï¼Œä¸­å›½åŠ æ²¹ï¼æ£‹æ‰‹æˆ˜é¹°#å·´é»å¥¥è¿ä¼š# æ£‹æ‰‹æˆ˜é¹°çš„å¾®åšè§†é¢‘</a></h1>
  <div class="date-author">
    
    <span class="date">2024-07-24</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5878312122-op3frtkhy/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted -->#å¥¥è¿ä¼š#<!-- raw HTML omitted --><!-- raw HTML omitted --> <!-- raw HTML omitted --><!-- raw HTML omitted -->#å·´é»å¥¥è¿ä¼š#<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> - è½¬å‘ <!-- raw HTML omitted -->@æ£‹æ‰‹æˆ˜é¹°<!-- raw HTML omitted -->:â€‚å·´é»å¥¥è¿ä¼šå³å°†åˆ°æ¥ï¼Œé¢„ç¥ä¸­å›½å¥¥è¿å¥å„¿ä»¬å‡¯æ—‹å½’æ¥ï¼Œä¸­å›½åŠ æ²¹ï¼&lt;a href=&ldquo;<a href="https://m.weibo.cn/p/index?extparam=%E6%A3%8B%E6%89%8B%E6%88%98%E9%B9%B0&amp;amp;containeri">https://m.weibo.cn/p/index?extparam=%E6%A3%8B%E6%89%8B%E6%88%98%E9%B9%B0&amp;amp;containeri</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5878312122/Op3y7oWfH">ä¸‰æ˜Ÿæ¯ç»¼åˆé¢„é€‰æ—¥æœ¬æ£‹æ‰‹å‚åŠ æƒ…å†µä¸€èˆ¬ç»„1ç»„ æ¨ªå¡šåŠ›2ç»„ é¹¤ç”°å’Œå¿— é…’äº•ä½‘è§„3ç»„ è¥¿å†ˆæ­£ç»‡ ä¼Šç”°ç¬ƒå² æ¡‘åŸæ ‘ é«˜æ¡¥è‰¯ä¾‘4ç»„ å…³èˆªå¤ªéƒ5ç»„ å¼ è±ŠçŒ·6ç»„ è¥¿å¥ä¼¸ æ²³è‹±ä¸€ å¹³ç”°æ™º...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-07-24</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5878312122-op3y7owfh/">
    
    
    
    
    
      
    
    ä¸‰æ˜Ÿæ¯ç»¼åˆé¢„é€‰æ—¥æœ¬æ£‹æ‰‹å‚åŠ æƒ…å†µ<!-- raw HTML omitted -->ä¸€èˆ¬ç»„<!-- raw HTML omitted -->1ç»„ æ¨ªå¡šåŠ›<!-- raw HTML omitted -->2ç»„ é¹¤ç”°å’Œå¿— é…’äº•ä½‘è§„<!-- raw HTML omitted -->3ç»„ è¥¿å†ˆæ­£ç»‡ ä¼Šç”°ç¬ƒå² æ¡‘åŸæ ‘ é«˜æ¡¥è‰¯ä¾‘<!-- raw HTML omitted -->4ç»„ å…³èˆªå¤ªéƒ<!-- raw HTML omitted -->5ç»„ å¼ è±ŠçŒ·<!-- raw HTML omitted -->6ç»„ è¥¿å¥ä¼¸ æ²³è‹±ä¸€ å¹³ç”°æ™ºä¹Ÿ æ²³åŸè£•<!-- raw HTML omitted -->7ç»„ ä¸°ç”°è£•ä» ç¦å†ˆèˆªå¤ªæœ— äº•å±±è£•å¤ª ç”°ä¸­åº·æ¹§<!-- raw HTML omitted -->8ç»„ ä»Šåˆ†å¤ªéƒ è¿‘è—¤ç™»å¿—å¸Œ ç«¹ä¸‹å‡ŒçŸ¢ ç†Šæœ¨ç†™å¼¥ æ²³é‡ä¸´ï¼ˆä»²é‚‘å ‡ï¼‰<!-- raw HTML omitted -->9ç»„ å¤§å·æ‹“ä¹Ÿ è¾»ç¬ƒä» è¡¨æ‚ æ–— å°æ¾å¤§æ ‘ å…­æµ¦é›„å¤ª<!-- raw HTML omitted -->10ç»„ ä¸­æ»¨å­ä¹‹è¾… æ‘å·å¤§ä»‹ <!-- raw HTML omitted -->11ç»„ è²ç‰¹æ‹‰ å®‰è¾¾åˆ©æ˜Œ å°è¥¿ç†ç«  å·ç«¯ç¬ƒå£« æ´ªçˆ½ç¾©<!-- raw HTML omitted -->12ç»„ è¥¿æ‘ä» æ¸¡è¾¹å®½å¤§ è§é’°æ´‹<!-- raw HTML omitted -->13ç»„ é‡å·æ˜å¸ ä¸‰æµ¦å¤ªéƒ è—¤äº•æµ©è´µ ä¼Šäº†<!-- raw HTML omitted --><!-- raw HTML omitted -->å…ƒè€ç»„<!-- raw HTML omitted -->1ç»„ å¤§çŸ¢æµ©ä¸€ æŸ³æ—¶ç† <!-- raw HTML omitted -->2ç»„ æ½˜å–„çª ä¹…ä¿ç§€å¤« ä¸­æ ¹ç›´è¡Œ å…³å±±åˆ©é“<!-- raw HTML omitted --><!-- raw HTML omitted -->å¥³å­ç»„<!-- raw HTML omitted -->1ç»„ å²©ç”°çº±ç»˜åŠ  è—¤æ³½é‡Œèœ å¥¥ç”°å½© ä¸Šé‡çˆ±å’²ç¾ æŸ³åŸå’²è¾‰ ä¸Šé‡æ¢¨çº± æ£®æ™ºå’² ç‰›è£å­<!-- raw HTML omitted -->2ç»„ ç¾½æ ¹å½©å¤ è°¢ä¾æ—» å¾æ–‡ç‡• åŠ è—¤ä¼˜å¸Œ<!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;a href=&ldquo;<a href="https://m.weibo.c">https://m.weibo.c</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5878312122/Op5U69fSD">å‘å¸ƒäº†å¤´æ¡æ–‡ç« ï¼šã€Šæ—¥æœ¬çš„å›´æ£‹äººæ°”èƒ½å¦è¿½ä¸Šå°†æ£‹ï¼Ÿã€‹ #å›´æ£‹# å›´æ£‹ #å¥¥è¿ä¼š# æ—¥æœ¬çš„å›´æ£‹äººæ°”èƒ½å¦è¿½ä¸Šå°†æ£‹ï¼Ÿ [å›¾ç‰‡]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-07-24</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5878312122-op5u69fsd/">
    
    
    
    
    
      
    
    å‘å¸ƒäº†å¤´æ¡æ–‡ç« ï¼šã€Šæ—¥æœ¬çš„å›´æ£‹äººæ°”èƒ½å¦è¿½ä¸Šå°†æ£‹ï¼Ÿã€‹ <!-- raw HTML omitted --><!-- raw HTML omitted -->#å›´æ£‹#<!-- raw HTML omitted --><!-- raw HTML omitted --> <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->å›´æ£‹<!-- raw HTML omitted --><!-- raw HTML omitted --> &lt;a &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5878312122/Op5w9yPBD">æ£‹æ‰‹æˆ˜é¹° [å›¾ç‰‡]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-07-24</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5878312122-op5w9ypbd/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->æ£‹æ‰‹æˆ˜é¹°<!-- raw HTML omitted --><!-- raw HTML omitted --> <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5878312122/Op616C5CS">ç¾½æ ¹ç›´æ ‘çš„å„¿å­å¤ªå¼ºï¼Œæ‹¿åˆ°å…¨å›½é«˜ä¸­ç”Ÿå›´æ£‹é€‰æ‰‹æƒå† å†›å»å¹´ç¬¬3ï¼Œä»Šå¹´å…¨èƒœå¤ºå† #å›´æ£‹#å›´æ£‹ [å›¾ç‰‡]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-07-24</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5878312122-op616c5cs/">
    
    
    
    
    
      
    
    ç¾½æ ¹ç›´æ ‘çš„å„¿å­å¤ªå¼ºï¼Œæ‹¿åˆ°å…¨å›½é«˜ä¸­ç”Ÿå›´æ£‹é€‰æ‰‹æƒå† å†›<!-- raw HTML omitted --><!-- raw HTML omitted -->å»å¹´ç¬¬3ï¼Œä»Šå¹´å…¨èƒœå¤ºå† <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->#å›´æ£‹#<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->å›´æ£‹&lt;/ &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/6015489225/Op4F2vwpd">ä¹…ä¿å²ç»ªé‡Œä¹ƒæœ¨æ‹ç™»é™†ç•Œé¢ &amp;ä¹ƒæœ¨æ‹å®˜X [å›¾ç‰‡][å›¾ç‰‡]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-07-24</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-6015489225-op4f2vwpd/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->ä¹…ä¿å²ç»ªé‡Œ<!-- raw HTML omitted --><!-- raw HTML omitted -->ä¹ƒæœ¨æ‹ç™»é™†ç•Œé¢ &amp;ä¹ƒæœ¨æ‹å®˜X <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;img style=&quot;&quot; src=&ldquo;<a href="https://tvax2.sinaimg.cn/large/006z6">https://tvax2.sinaimg.cn/large/006z6</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/6015489225/Op5U8olgo">ä¹…ä¿å²ç»ªé‡Œ#shiorigram# ç¨å25:00ï½ï¼ˆJSTï¼‰æ—¥æœ¬æ”¾é€ã€ä¹ƒæœ¨å‚46çš„ANNã€è¯·ä¸€å®šè¦å¬ï½ğŸ°å¼“æœ¨çš„å¥ˆæ–¼é…±ä¼šæ¥å“¦ï½å¥½é«˜å…´ï¼Œå¥½å–œæ¬¢ï¼Œå¥½é«˜å…´ã€‚ [å›¾ç‰‡]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-07-24</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-6015489225-op5u8olgo/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->ä¹…ä¿å²ç»ªé‡Œ<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->#shiorigram#&lt;/sp &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/6015489225/Op5XvoDWL">ä¹…ä¿å²ç»ªé‡Œvia.ä¹ƒæœ¨å‚46 &amp;NOGI46ann X [å›¾ç‰‡][å›¾ç‰‡]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-07-24</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-6015489225-op5xvodwl/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->ä¹…ä¿å²ç»ªé‡Œ<!-- raw HTML omitted --><!-- raw HTML omitted -->via.ä¹ƒæœ¨å‚46 &amp;NOGI46ann X <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;img style=&quot;&quot; src=&ldquo;<a href="https://tvax1.sinaimg.cn/large/006z">https://tvax1.sinaimg.cn/large/006z</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/7332621109/Op2Ljyyff">æŸ¯æ´#èµ›äº‹é¢„å‘Š##ä¸‰æ˜Ÿæ¯é¢„é€‰#ä¸‰æ˜Ÿæ¯ç»¼åˆé¢„é€‰äº8æœˆ26è‡³31æ—¥åœ¨éŸ©å›½ä¸¾è¡Œï¼ŒæŸ¯æ´ä¹æ®µé¦–è½®è½®ç©ºã€‚[èµ¢ç‰›å¥¶]ä»Šå¹´çš„ä¸‰æ˜Ÿé¢„é€‰åŠ æ²¹ã€‚ [å›¾ç‰‡]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-07-24</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-7332621109-op2ljyyff/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->æŸ¯æ´<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->#èµ›äº‹é¢„å‘Š#<!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;a href=&ldquo;<a href="https://m.weibo.cn/">https://m.weibo.cn/</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://www.bilibili.com/video/BV17T42167v2">æœªæ¥çš„æ— äººå‡ºç§Ÿè½¦å‘å±•ä¸‹å»ä¼šæ˜¯ä»€ä¹ˆæ ·å­ï¼Ÿ</a></h1>
  <div class="date-author">
    
    <span class="date">2024-07-24</span>
  </div>
  <div class="summary">
    <a href="/post/www-bilibili-com-video-bv17t42167v2/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://www.bilibili.com/video/BV17x4y147Ab">ç›´21æ¥äº†ï¼ä¸ºä»€ä¹ˆä¸­å›½é™†èˆªå¿…é¡»è£…å¤‡é‡å‹æ­¦ç›´ï¼Ÿ</a></h1>
  <div class="date-author">
    
    <span class="date">2024-07-24</span>
  </div>
  <div class="summary">
    <a href="/post/www-bilibili-com-video-bv17x4y147ab/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://www.bilibili.com/video/BV1dM4m1y79q">[4K] 36th.ã€Cheat Dayã€- å¤å·¡2024Ver.</a></h1>
  <div class="date-author">
    
    <span class="date">2024-07-24</span>
  </div>
  <div class="summary">
    <a href="/post/www-bilibili-com-video-bv1dm4m1y79q/">
    
    
    
    
    
      
    
    -<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://www.bilibili.com/video/BV1E2421Z78L">å½“æˆ‘ç¡å‰å¬åˆ«çš„å¥³äººè®²æ•…äº‹ï¼Œåª³å¦‡å¥¹ç«Ÿç„¶â€¦â€¦</a></h1>
  <div class="date-author">
    
    <span class="date">2024-07-24</span>
  </div>
  <div class="summary">
    <a href="/post/www-bilibili-com-video-bv1e2421z78l/">
    
    
    
    
    
      
    
    -<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://www.bilibili.com/video/BV1uT421r71T">ç½‘çº¢è¥é”€çš„ä¸€ä¸‡ç§å¥—è·¯ï¼Œéƒ½åœ¨è¿™äº†ï¼</a></h1>
  <div class="date-author">
    
    <span class="date">2024-07-24</span>
  </div>
  <div class="summary">
    <a href="/post/www-bilibili-com-video-bv1ut421r71t/">
    
    
    
    
    
      
    
    äº’è”ç½‘æ—¶ä»£çš„è¥é”€å±€â€¦â€¦<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://www.bilibili.com/video/BV1zU411U7cc">æœ€æ–°å›´ç”²ï¼šæè½©è±ªæ”»é˜²ä¸€ä½“åŒæ–™æ€å±€ï¼æ”»æ€é£é›¨ä¸é€ï¼Œæ²»å­¤ä¸‡ç®­é½å‘</a></h1>
  <div class="date-author">
    
    <span class="date">2024-07-24</span>
  </div>
  <div class="summary">
    <a href="/post/www-bilibili-com-video-bv1zu411u7cc/">
    
    
    
    
    
      
    
    æœ€æ–°å›´ç”²ï¼šæè½©è±ªæ”»é˜²ä¸€ä½“åŒæ–™æ€å±€ï¼æ”»æ€é£é›¨ä¸é€ï¼Œæ²»å­¤ä¸‡ç®­é½å‘<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://zhuanlan.zhihu.com/p/710626729">é‡å­ä½å‘è¡¨äº†æ–‡ç« : è®©AIè§†é¢‘è¿›å…¥ã€Œå…¨æ°‘GCã€æ—¶ä»£ï¼Œè¿™å®¶ä¸­å›½å…¬å¸åˆšåˆšçœŸçš„åšåˆ°äº†</a></h1>
  <div class="date-author">
    
    <span class="date">2024-07-24</span>
  </div>
  <div class="summary">
    <a href="/post/zhuanlan-zhihu-com-p-710626729/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted -->
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://zhuanlan.zhihu.com/p/710628972">é‡å­ä½å‘è¡¨äº†æ–‡ç« : è´¾æ‰¬æ¸…å…±ä¸€è®ºæ–‡è·ICMLæ—¶é—´æ£€éªŒå¥–ï¼šé¦–ä¸ªå¼€æºç‰ˆAlexNetï¼Œè‘—åæ¡†æ¶Caffeå‰èº«ï¼Œæœ€ä½³è®ºæ–‡å¥–ä¹Ÿå·²å…¬å¸ƒ</a></h1>
  <div class="date-author">
    
    <span class="date">2024-07-24</span>
  </div>
  <div class="summary">
    <a href="/post/zhuanlan-zhihu-com-p-710628972/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted -->
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://zhuanlan.zhihu.com/p/710629248">é‡å­ä½å‘è¡¨äº†æ–‡ç« : åŒ—å¤§åˆ˜è‹¥å·æ•™æˆè·æ‹‰é©¬åŠªé‡‘å¥–ï¼Œä¸­å›½å­¦è€…4æ¬¡è·æ­¤æ®Šè£</a></h1>
  <div class="date-author">
    
    <span class="date">2024-07-24</span>
  </div>
  <div class="summary">
    <a href="/post/zhuanlan-zhihu-com-p-710629248/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted -->
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://zhuanlan.zhihu.com/p/710631749">é‡å­ä½å‘è¡¨äº†æ–‡ç« : æ¸¯å¤§é©¬æ¯…ï¼šå¤§æ¨¡å‹é•¿æœŸæ²¡æœ‰ç†è®ºå°±åƒç›²äººæ‘¸è±¡ï¼›å¤§ä½¬é½èšè°ˆAIä¸‹ä¸€æ­¥</a></h1>
  <div class="date-author">
    
    <span class="date">2024-07-24</span>
  </div>
  <div class="summary">
    <a href="/post/zhuanlan-zhihu-com-p-710631749/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted -->
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://zhuanlan.zhihu.com/p/710668562">é‡å­ä½å‘è¡¨äº†æ–‡ç« : GPT-4o miniç™»é¡¶å¤§æ¨¡å‹ç«æŠ€åœºï¼Œå¥¥ç‰¹æ›¼ï¼šä¸¤ä¸ªæœˆå†…å¾®è°ƒå…è´¹</a></h1>
  <div class="date-author">
    
    <span class="date">2024-07-24</span>
  </div>
  <div class="summary">
    <a href="/post/zhuanlan-zhihu-com-p-710668562/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted -->
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://zhuanlan.zhihu.com/p/710675475">é‡å­ä½å‘è¡¨äº†æ–‡ç« : å¿«æ‰‹å¯çµç‡å…ˆå…¨é¢å¼€æ”¾ï¼äººäººå¯ç”¨ï¼Œæ”¶è´¹æ¨¡å¼ä¹Ÿæ­å¥½äº†</a></h1>
  <div class="date-author">
    
    <span class="date">2024-07-24</span>
  </div>
  <div class="summary">
    <a href="/post/zhuanlan-zhihu-com-p-710675475/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted -->
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://zhuanlan.zhihu.com/p/710742862">é‡å­ä½å‘è¡¨äº†æ–‡ç« : è‹±ç‰¹å°”ä¸¾åŠ2024ç½‘ç»œä¸è¾¹ç¼˜è®¡ç®—è¡Œä¸šå¤§ä¼šï¼Œæ¨åŠ¨è¾¹ç¼˜AIåˆ›æ–°å‘å±•</a></h1>
  <div class="date-author">
    
    <span class="date">2024-07-24</span>
  </div>
  <div class="summary">
    <a href="/post/zhuanlan-zhihu-com-p-710742862/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted -->
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39039746/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240723183324&amp;v=2.18.0.post9&#43;e462414">Testosterone in prevention and treatment of type 2 diabetes in men: Focus on recent randomized controlled trials</a></h1>
  <div class="date-author">
    
    <span class="date">2024-07-23</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39039746-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240723183324-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    In epidemiological studies, lowered serum testosterone concentrations are common in men with obesity, prediabetes, and established type 2 diabetes (T2D). In men with prediabetes, lowered serum testosterone also predicts a future risk of T2D in men. Administration of testosterone consistently reduces fat mass and increases skeletal muscle mass-body compositional changes expected to be metabolically favorable. In men with established T2D, the effects of testosterone treatment on glycemic &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39039821/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240723183324&amp;v=2.18.0.post9&#43;e462414">When the going gets tough, the tough get going-Novel bacterial AAA&#43; disaggregases provide extreme heat resistance</a></h1>
  <div class="date-author">
    
    <span class="date">2024-07-23</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39039821-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240723183324-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Heat stress can lead to protein misfolding and aggregation, potentially causing cell death due to the loss of essential proteins. Bacteria, being particularly exposed to environmental stress, are equipped with disaggregases that rescue these aggregated proteins. The bacterial Hsp70 chaperone DnaK and the ATPase associated with diverse cellular activities protein ClpB form the canonical disaggregase in bacteria. While this combination operates effectively during physiological heat stress, it &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39040028/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240723183324&amp;v=2.18.0.post9&#43;e462414">Vitamin B12 Deficiency Newborn Screening</a></h1>
  <div class="date-author">
    
    <span class="date">2024-07-23</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39040028-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240723183324-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSIONS: NBS for neonatal VitB12D may lead to a fourfold risk reduction of developing symptomatic VitB12D in the first year of life compared with infants without &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39040074/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240723183324&amp;v=2.18.0.post9&#43;e462414">Explainable machine learning for predicting 30-day readmission in acute heart failure patients</a></h1>
  <div class="date-author">
    
    <span class="date">2024-07-23</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39040074-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240723183324-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    We aimed to develop a machine-learning based predictive model to identify 30-day readmission risk in Acute heart failure (AHF) patients. In this study 2232 patients hospitalized with AHF were included. The variance inflation factor value and 5-fold cross-validation were used to select vital clinical variables. Five machine learning algorithms with good performance were applied to develop models, and the discrimination ability was comprehensively evaluated by sensitivity, specificity, and &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39040102/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240723183324&amp;v=2.18.0.post9&#43;e462414">Dual roles of CD11b&lt;sup&gt;&#43;&lt;/sup&gt;CD33&lt;sup&gt;&#43;&lt;/sup&gt;HLA-DR&lt;sup&gt;-/low&lt;/sup&gt;CD14&lt;sup&gt;-&lt;/sup&gt; myeloid-derived suppressor cells with a granulocytic morphology following allogeneic hematopoietic stem cell transplantation: from inflammation promoters to immune suppressors within 90 days</a></h1>
  <div class="date-author">
    
    <span class="date">2024-07-23</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39040102-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240723183324-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSION: Our findings revealed the alteration in the immune characteristics of G-MDSCs within the first 90 days post-allo-HSCT. Moreover, the quantity of G-MDSCs at day 28 may serve as a predictive indicator for the development of &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39040529/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240723183324&amp;v=2.18.0.post9&#43;e462414">A climatic suitability indicator to support &lt;em&gt;Leishmania infantum&lt;/em&gt; surveillance in Europe: a modelling study</a></h1>
  <div class="date-author">
    
    <span class="date">2024-07-23</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39040529-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240723183324-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    BACKGROUND: Leishmaniases are neglected diseases transmitted by sand flies. They disproportionately affect vulnerable groups globally. Understanding the relationship between climate and disease transmission allows the development of relevant decision-support tools for public health policy and surveillance. The aim of this modelling study was to develop an indicator that tracks climatic suitability for Leishmania infantum transmission in Europe at the subnational &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39040589/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240723183324&amp;v=2.18.0.post9&#43;e462414">Get a move on: physical (in)activity in people with obstructive airway disease</a></h1>
  <div class="date-author">
    
    <span class="date">2024-07-23</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39040589-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240723183324-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    A study extended the &ldquo;can do, do do&rdquo; concept in people with obstructive airways disease to demonstrate different clinical and movement behaviour characteristics based on quadrant classification, and proposed a treatable traits approach to management <a href="https://bit.ly/4cOGlN5">https://bit.ly/4cOGlN5</a>. &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39041188/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240723183324&amp;v=2.18.0.post9&#43;e462414">Proteomic profiling improves prognostic risk stratification of the Sarculator nomogram in soft tissue sarcomas of the extremities and trunk wall</a></h1>
  <div class="date-author">
    
    <span class="date">2024-07-23</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39041188-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240723183324-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSIONS: Risk stratification of patient with STS is defined by distinct biological pathways across a range of cancer hallmarks. Incorporation of SPM6 protein signature improves prognostic risk stratification of the Sarculator nomogram. This study highlights the utility of integrating protein signatures for the development of next-generation &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39041353/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240723183324&amp;v=2.18.0.post9&#43;e462414">The most impactful endometriosis symptom: An international, cross-sectional, two-round survey study</a></h1>
  <div class="date-author">
    
    <span class="date">2024-07-23</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39041353-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240723183324-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSIONS: There was substantial variation in the symptom selected as causing the most impact, and the level of impact was high. A focus on measuring the &ldquo;most impactful symptom&rdquo; in future research may enable us to better capture and measure the true symptom &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39041435/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240723183324&amp;v=2.18.0.post9&#43;e462414">Harmonizing tau positron emission tomography in Alzheimer&#39;s disease: The CenTauR scale and the joint propagation model</a></h1>
  <div class="date-author">
    
    <span class="date">2024-07-23</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39041435-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240723183324-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    INTRODUCTION: Tau-positron emission tomography (PET) outcome data of patients with Alzheimer&rsquo;s disease (AD) cannot currently be meaningfully compared or combined when different tracers are used due to differences in tracer properties, instrumentation, and methods of &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39041775/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240723183324&amp;v=2.18.0.post9&#43;e462414">Rapid Online Data Collection and Reporting to Local Health Departments during the Pandemic: The COVID-19 Outbreak Public Evaluation (COPE) Initiative SARS-CoV-2 Case Surveys</a></h1>
  <div class="date-author">
    
    <span class="date">2024-07-23</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39041775-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240723183324-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSION: This project demonstrates the feasibility of a centralized, rapid, and adaptive data collection system for local health departments and provides evidence to advocate for data collection methods to help guide local health departments to respond in a timely and effective manner to future public health &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39041937/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240723183324&amp;v=2.18.0.post9&#43;e462414">Weakly Supervised Deep Learning in Radiology</a></h1>
  <div class="date-author">
    
    <span class="date">2024-07-23</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39041937-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240723183324-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Deep learning (DL) is currently the standard artificial intelligence tool for computer-based image analysis in radiology. Traditionally, DL models have been trained with strongly supervised learning methods. These methods depend on reference standard labels, typically applied manually by experts. In contrast, weakly supervised learning is more scalable. Weak supervision comprises situations in which only a portion of the data are labeled (incomplete supervision), labels refer to a whole &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39042027/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240723183324&amp;v=2.18.0.post9&#43;e462414">High PEEP with recruitment maneuvers versus Low PEEP During General Anesthesia for Surgery - a Bayesian individual patient data meta-analysis of three randomized clinical trials</a></h1>
  <div class="date-author">
    
    <span class="date">2024-07-23</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39042027-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240723183324-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSION: High PEEP with recruitment maneuvers demonstrated a moderate reduction in the probability of PPC occurrence, with a high posterior probability of benefit observed consistently across various prior beliefs, particularly among patients who underwent &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39042381/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1Rkszs2HVZ2RHP33OibaNFew6VK-LzjJWTD4GwmLlk8B-wCceh&amp;fc=20220923065203&amp;ff=20240723183316&amp;v=2.18.0.post9&#43;e462414">Vitamin D insufficiency in CLL: a modifiable prognostic factor?</a></h1>
  <div class="date-author">
    
    <span class="date">2024-07-23</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39042381-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1rkszs2hvz2rhp33oibanfew6vk-lzjjwtd4gwmllk8b-wcceh-fc-20220923065203-ff-20240723183316-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39042381/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1Rkszs2HVZ2RHP33OibaNFew6VK-LzjJWTD4GwmLlk8B-wCceh&amp;fc=20220923065203&amp;ff=20240724182938&amp;v=2.18.0.post9&#43;e462414">Vitamin D insufficiency in CLL: a modifiable prognostic factor?</a></h1>
  <div class="date-author">
    
    <span class="date">2024-07-23</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39042381-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1rkszs2hvz2rhp33oibanfew6vk-lzjjwtd4gwmllk8b-wcceh-fc-20220923065203-ff-20240724182938-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39042402/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240723183324&amp;v=2.18.0.post9&#43;e462414">Myopic Macular Atrophy in the Two-Continent Population-Based Study</a></h1>
  <div class="date-author">
    
    <span class="date">2024-07-23</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39042402-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240723183324-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSIONS: All eyes with assessable myopic macular atrophy showed foveal BMDs associated with SRPs, while patchy atrophies could be differentiated into those with BMDs and SRPs and those without BMDs and without SRPs. Independent of the MMD stage, the prevalences of BMDs and SRPs were highly significantly associated with each &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39042429/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240723183324&amp;v=2.18.0.post9&#43;e462414">Pooled Cohort Profile: ReCoDID Consortium&#39;s Harmonized Acute Febrile Illness Arbovirus Meta-Cohort</a></h1>
  <div class="date-author">
    
    <span class="date">2024-07-23</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39042429-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240723183324-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Infectious disease (ID) cohorts are key to advancing public health surveillance, public policies, and pandemic responses. Unfortunately, ID cohorts often lack funding to store and share clinical-epidemiological (CE) data and high-dimensional laboratory (HDL) data long term, which is evident when the link between these data elements is not kept up to date. This becomes particularly apparent when smaller cohorts fail to successfully address the initial scientific objectives due to limited &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39042456/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240723183324&amp;v=2.18.0.post9&#43;e462414">Identifying Predictors of Heart Failure Readmission in Patients From a Statutory Health Insurance Database: Retrospective Machine Learning Study</a></h1>
  <div class="date-author">
    
    <span class="date">2024-07-23</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39042456-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240723183324-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSIONS: While many of the predictors we identified were known to be relevant comorbidities for HF, we also uncovered several novel associations. Disease management programs have widely been shown to be effective at managing chronic disease; however, our results indicate that in the short term they may be useful for targeting patients with HF with comorbidity at increased risk of readmission. Our results also show that living in a more rural location increases the risk of &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39042520/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240724183054&amp;v=2.18.0.post9&#43;e462414">WONOEP appraisal: Modeling early onset epilepsies</a></h1>
  <div class="date-author">
    
    <span class="date">2024-07-23</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39042520-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240724183054-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Epilepsy has a peak incidence during the neonatal to early childhood period. These early onset epilepsies may be severe conditions frequently associated with comorbidities such as developmental deficits and intellectual disability and, in a significant percentage of patients, may be medication-resistant. The use of adult rodent models in the exploration of mechanisms and treatments for early life epilepsies is challenging, as it ignores significant age-specific developmental differences. &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39042903/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1Rkszs2HVZ2RHP33OibaNFew6VK-LzjJWTD4GwmLlk8B-wCceh&amp;fc=20220923065203&amp;ff=20240724182938&amp;v=2.18.0.post9&#43;e462414">Clinical Outcomes After Idecabtagene Vicleucel in Older Multiple Myeloma Patients: A Multicenter Real-world Experience</a></h1>
  <div class="date-author">
    
    <span class="date">2024-07-23</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39042903-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1rkszs2hvz2rhp33oibanfew6vk-lzjjwtd4gwmllk8b-wcceh-fc-20220923065203-ff-20240724182938-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    The safety and efficacy of CAR T-cell therapy is not well described in older patients, a population that has higher frailty and co-morbidities. In this multicenter retrospective study, we evaluated clinical outcomes along with frailty and geriatric characteristics such as comorbidities, polypharmacy, falls, neuropathy, organ dysfunction, and performance status in younger (&lt;65 years) versus older (â‰¥65 years) patients who received commercial idecabtagene vicleucel (ide-cel). A total of &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39043035/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240724183054&amp;v=2.18.0.post9&#43;e462414">Long-term Outcome After Helical Tomotherapy Following Breast Conserving Surgery for Ductal Carcinoma In Situ</a></h1>
  <div class="date-author">
    
    <span class="date">2024-07-23</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39043035-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240724183054-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Background: This retrospective study aimed to investigate the outcomes and adverse events (AEs) associated with adjuvant radiotherapy with helical tomotherapy (hT) after breast-conserving surgery (BCS) for ductal carcinoma in situ (DCIS). Methods: Twenty-eight patients with DCIS underwent postoperative hT between 2011 and 2020. hT was chosen since it provided optimal target coverage and tolerable organ-at-risk doses to the lungs and heart when tangential 3-dimensional conformal &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39043129/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240724183054&amp;v=2.18.0.post9&#43;e462414">Peri-operative care of transgender and gender-diverse individuals: guidance for clinicians and departments</a></h1>
  <div class="date-author">
    
    <span class="date">2024-07-23</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39043129-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240724183054-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSIONS: This document provides the first guidance produced to advise on best practice to ensure the safety and dignity of trans and gender-diverse individuals in the peri-operative &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39043180/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240724183054&amp;v=2.18.0.post9&#43;e462414">Innate immune memory after brain injury drives inflammatory cardiac dysfunction</a></h1>
  <div class="date-author">
    
    <span class="date">2024-07-23</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39043180-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240724183054-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    The medical burden of stroke extends beyond the brain injury itself and is largely determined by chronic comorbidities that develop secondarily. We hypothesized that these comorbidities might share a common immunological cause, yet chronic effects post-stroke on systemic immunity are underexplored. Here, we identify myeloid innate immune memory as a cause of remote organ dysfunction after stroke. Single-cell sequencing revealed persistent pro-inflammatory changes in monocytes/macrophages &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39043205/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240724183054&amp;v=2.18.0.post9&#43;e462414">Oral Cavity Squamous Cell Carcinoma: Impact of Clear Margin Distance on Locoregional Control in Patients Undergoing Postoperative Radiotherapy</a></h1>
  <div class="date-author">
    
    <span class="date">2024-07-23</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39043205-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240724183054-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSION: Patients who have narrow resection margins (1-5 mm) experience poor local control and should receive postoperative radiotherapy. It is necessary to conduct further prospective studies to determine whether a narrower margin window could be achieved to better determine the appropriate indication for adjuvant &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39043549/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240724183054&amp;v=2.18.0.post9&#43;e462414">Re: Overall Survival with Adjuvant Pembrolizumab in Renal-cell Carcinoma</a></h1>
  <div class="date-author">
    
    <span class="date">2024-07-23</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39043549-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240724183054-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39043693/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240724183054&amp;v=2.18.0.post9&#43;e462414">Multiomic profiling of medulloblastoma reveals subtype-specific targetable alterations at the proteome and N-glycan level</a></h1>
  <div class="date-author">
    
    <span class="date">2024-07-23</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39043693-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240724183054-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Medulloblastomas (MBs) are malignant pediatric brain tumors that are molecularly and clinically heterogenous. The application of omics technologies-mainly studying nucleic acids-has significantly improved MB classification and stratification, but treatment options are still unsatisfactory. The proteome and their N-glycans hold the potential to discover clinically relevant phenotypes and targetable pathways. We compile a harmonized proteome dataset of 167 MBs and integrate findings with &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39044087/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240724183054&amp;v=2.18.0.post9&#43;e462414">Production and Purification of Adeno-Associated Viral Vectors for the Development of Immune-Competent Mouse Models of Persistent Hepatitis B Virus Replication</a></h1>
  <div class="date-author">
    
    <span class="date">2024-07-23</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39044087-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240724183054-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Mice infected with a recombinant adeno-associated virus carrying a replication-competent hepatitis B virus genome (rAAV-HBV) via the intravenous route establish a persistent HBV replication in hepatocytes and develop immune tolerance. They serve as models to evaluate antiviral immunity and to assess potential therapeutic approaches for chronic HBV infection. Combining selected HBV variants and different mouse genotypes allows for addressing a broad spectrum of research questions. This &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1251560221/OoRe1u4HM">è¿™å‘¨æ˜¯IAS AIDS 2024å¤§ä¼šï¼Œå¾ˆå¤šé‡è¦æœŸåˆŠä¼šå‘è¡¨HIVç ”ç©¶ï¼ˆè¿™è¢«å«åšparallel publication - ä¼šè®®æœŸåˆŠåŒæ­¥å‘è¡¨ï¼‰ã€‚Lancet IDå‘è¡¨äº†è‘—åçš„å¤±è´¥ç ”ç©¶HVTN 705ï¼ˆç½‘é¡µé“¾æ¥...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-07-23</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1251560221-oore1u4hm/">
    
    
    
    
    
      
    
    è¿™å‘¨æ˜¯IAS AIDS 2024å¤§ä¼šï¼Œå¾ˆå¤šé‡è¦æœŸåˆŠä¼šå‘è¡¨HIVç ”ç©¶ï¼ˆè¿™è¢«å«åšparallel publication - ä¼šè®®æœŸåˆŠåŒæ­¥å‘è¡¨ï¼‰ã€‚Lancet IDå‘è¡¨äº†è‘—åçš„å¤±è´¥ç ”ç©¶HVTN 705ï¼ˆ<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->ç½‘é¡µé“¾æ¥<!-- raw HTML omitted --><!-- raw HTML omitted -->ï¼‰Imbokodoï¼Œè¯¥ç ”ç©¶åº”ç”¨äº†Barouchç»„å¼€å‘çš„Ad26.Mos4.HIV+é“ä½å‰‚gp140è¿›è¡ŒHIV-1é¢„é˜²æ€§ç–«è‹—å¼€å‘ã€‚<!-- raw HTML omitted --><!-- raw HTML omitted -->ç ”ç©¶åœ¨éæ´²å…¥ç»„äº†2654åå¥³æ€§ã€‚é¦–æ¬¡æ¥ç§ç–«è‹—å7-24ä¸ªæœˆå†…ï¼Œç–«è‹—ç»„æ¯100äººå¹´HIV-1æ„ŸæŸ“ç‡ &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1251560221/OoSad7MI2">æˆ‘éå¸¸å–œæ¬¢ä¹Ÿä¸€ç›´å…³æ³¨çš„The Atlanticï¼ˆå¤§è¥¿æ´‹æœˆåˆŠï¼‰ä¸“æ ä½œå®¶ã€å‰Politicoæ”¿æ²»ä¸»ç¼–ã€å†™äº†æˆ‘æ›¾æ¨èè¿‡çš„American Carnageè‘—åæ”¿æ²»è®°è€…Tim Albertaåœ¨The Atlanticå‘...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-07-23</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1251560221-oosad7mi2/">
    
    
    
    
    
      
    
    æˆ‘éå¸¸å–œæ¬¢ä¹Ÿä¸€ç›´å…³æ³¨çš„The Atlanticï¼ˆå¤§è¥¿æ´‹æœˆåˆŠï¼‰ä¸“æ ä½œå®¶ã€å‰Politicoæ”¿æ²»ä¸»ç¼–ã€å†™äº†æˆ‘æ›¾æ¨èè¿‡çš„American Carnageè‘—åæ”¿æ²»è®°è€…Tim Albertaåœ¨The Atlanticå‘è¡¨äº†ä¸€ç¯‡ååˆ†å¥½çš„æ–‡ç«  - This Is Exactly What the Trump Team Fearedï¼ˆè¿™å°±æ˜¯Trumpå›¢é˜Ÿæœ€æ€•çš„ï¼‰ã€‚è¿™ç¯‡æ–‡ç« ä¸æ˜¯ç©ºç©´æ¥é£çš„ä¸ªäººè§‚ç‚¹ï¼Œè€Œæ˜¯æ¥è‡ªäºé‡‡è®¿Trump 2024ç«é€‰ç»ç†ï¼ˆcampaign managersï¼‰Chris LaCivitaå’ŒSusie Wilesåçš„çºªè¦ã€‚è¿™ç¯‡æ–‡ç« ä¸­ï¼ŒTim Albertaè¯´Trump 2024å¹´çš„ä¸¤ä¸ªç«é€‰ç»ç†æœ€æ€•çš„ä¸€ç‚¹å°±æ˜¯æ°‘ä¸»å…šï¼ˆDemï¼‰åƒ2020å¹´ä¸€æ ·ç©ºå‰å›¢ç»“ã€‚<!-- raw HTML omitted --><!-- raw HTML omitted -->æˆ‘çœ‹äº†å¾ˆå¤šå¹´campaignï¼ŒæŠ›å¼€Trumpæœ¬èº«ä¸è¯´ï¼Œä¸å¾—ä¸è¯´ï¼ŒTrump 2024çš„ä¸¤ä¸ªcampaign managers - Chris LaCivitaå’ŒSusie &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1251560221/OoSZreBUw">å¯¹äºä¸çŸ¥é“è¿™ä¸ªå¸¸è¯†çš„æœ‹å‹ï¼Œæˆ‘è§‰å¾—æˆ‘æœ‰å¿…è¦å†æ¬¡å®£ä¼ ã€‚ä¸­å›½æ³•å®šçš„8ç§æ€§ç—…ä¸­çš„4ç§ - æ¢…æ¯’ã€æ·‹ç—…ã€è¡£åŸä½“å¼•èµ·çš„éæ·‹èŒæ€§å°¿é“ç‚ã€æ€§ç—…æ·‹å·´è‚‰èŠ½è‚¿æ˜¯å¯ä»¥é«˜æ•ˆé¢„é˜²çš„ï¼Œ...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-07-23</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1251560221-ooszrebuw/">
    
    
    
    
    
      
    
    å¯¹äºä¸çŸ¥é“è¿™ä¸ªå¸¸è¯†çš„æœ‹å‹ï¼Œæˆ‘è§‰å¾—æˆ‘æœ‰å¿…è¦å†æ¬¡å®£ä¼ ã€‚ä¸­å›½æ³•å®šçš„8ç§æ€§ç—…ä¸­çš„4ç§ - æ¢…æ¯’ã€æ·‹ç—…ã€è¡£åŸä½“å¼•èµ·çš„éæ·‹èŒæ€§å°¿é“ç‚ã€æ€§ç—…æ·‹å·´è‚‰èŠ½è‚¿æ˜¯å¯ä»¥é«˜æ•ˆé¢„é˜²çš„ï¼Œå°±æ˜¯åœ¨é«˜å±ï¼ˆæ— ä¿æŠ¤ï¼‰æ€§è¡Œä¸ºåçš„72å°æ—¶å†…æœç”¨200æ¯«å…‹å¤šè¥¿ç¯ç´ ï¼ˆå¼ºåŠ›éœ‰ç´ ï¼‰ã€‚å¤šè¥¿ç¯ç´ ä»·æ ¼ä¾¿å®œï¼Œååˆ†å®¹æ˜“è·å¾—ã€‚<!-- raw HTML omitted --><!-- raw HTML omitted --> - è½¬å‘ <!-- raw HTML omitted -->@å­é™µåœ¨å¬æ­Œ<!-- raw HTML omitted -->:â€‚ç¾å›½CDCæ­£å¼å¼€å§‹æ¨èDoxyPEPç”¨äºæš´éœ²åé¢„é˜²æ€§ä¼ æ’­ç–¾ç—…ï¼ˆSTIï¼‰ã€‚è¿™å…¶å®å¯¹å›½å†…ä¹Ÿæœ‰é‡è¦å€Ÿé‰´æ„ä¹‰ã€‚DoxyæŒ‡Doxycyclineï¼Œå³å¸¸è§æŠ—ç”Ÿç´ å¼ºåŠ›éœ‰ç´ ï¼ˆå¤šè¥¿ç¯ç´ ï¼‰ã€‚å‘è¡¨åœ¨NEJMçš„å¤§å‹ä¸´åºŠè¯•éªŒå‘ç°ï¼Œåœ¨æ— ä¿æŠ¤æ€§è¡Œä¸º72å°æ—¶å†…æœç”¨200mg Doxyï¼Œå¯ä»¥å°†ä¸‰ç§æœ€å¸¸è§STIï¼ˆæ¢…æ¯’ã€æ·‹ç—…ã€è¡£åŸä½“æ€§ç—…Chlamydiaï¼‰çš„å‘ç”Ÿç‡é™ä½62%ï¼ˆ&lt;a href=&ldquo;<a href="https://weibo.com/1251560221/4887809791362127%22">https://weibo.com/1251560221/4887809791362127&quot;</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1251560221/OoYs5jbuI">å‘¨æ—¥Bidené€€é€‰åç¬¬ä¸€ä¸ªä¸»è¦æ°‘è°ƒï¼ˆpollï¼‰å‡ºç‚‰ï¼Œç”±è·¯é€ç¤¾ï¼ˆReutersï¼‰èµ„åŠ©ï¼ŒIpsoså¼€å±•ã€‚1018ä¸ªæ³¨å†Œé€‰æ°‘ä¸­å¦‚æœä»…ä¸ºHarriså’ŒTrumpï¼ŒHarris: Trump = 44%: 42%ã€‚å¦‚æœåŠ ...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-07-23</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1251560221-ooys5jbui/">
    
    
    
    
    
      
    
    å‘¨æ—¥Bidené€€é€‰åç¬¬ä¸€ä¸ªä¸»è¦æ°‘è°ƒï¼ˆpollï¼‰å‡ºç‚‰ï¼Œç”±è·¯é€ç¤¾ï¼ˆReutersï¼‰èµ„åŠ©ï¼ŒIpsoså¼€å±•ã€‚1018ä¸ªæ³¨å†Œé€‰æ°‘ä¸­å¦‚æœä»…ä¸ºHarriså’ŒTrumpï¼ŒHarris: Trump = 44%: 42%ã€‚å¦‚æœåŠ ä¸ŠRFK Jrï¼Œåˆ™Harris: Trump: RFK Jr = 42%: 38%: 8%ï¼ˆ1241æˆäººå—è®¿è€…ï¼Œä¸¤ä¸ªæ¯”ä¾‹åˆ†åˆ«æ˜¯39%: 39%å’Œ37%: 34%: 10%ï¼‰ã€‚<!-- raw HTML omitted --><!-- raw HTML omitted -->#ç¾å›½2024å¹´æ€»ç»Ÿå¤§é€‰#<!-- raw HTML omitted --><!-- raw HTML omitted --> &lt;img style=&quot;&quot; src=&ldquo;<a href="https://tvax2.sinaimg.cn/">https://tvax2.sinaimg.cn/</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/3825863518/OoSfAuW1i">æˆ‘çœŸçš„æ˜¯å¾ˆè´¹è§£ï¼Œä¸€ä¸ªèŒä¸šçš„è®°è°±ï¼Œä¸è·Ÿè¿›åº¦ï¼Œ</a></h1>
  <div class="date-author">
    
    <span class="date">2024-07-23</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-3825863518-oosfauw1i/">
    
    
    
    
    
      
    
    æˆ‘çœŸçš„æ˜¯å¾ˆè´¹è§£ï¼Œä¸€ä¸ªèŒä¸šçš„è®°è°±ï¼Œä¸è·Ÿè¿›åº¦ï¼Œ  &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/3825863518/OoSrHrewP">é‡å‘ã€‚ - è½¬å‘ @æ­£å®—æ¯’å¥¶è‡:&amp;ensp;é‡å‘ã€‚ [å›¾ç‰‡]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-07-23</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-3825863518-oosrhrewp/">
    
    
    
    
    
      
    
    é‡å‘ã€‚<!-- raw HTML omitted --><!-- raw HTML omitted --> - è½¬å‘ <!-- raw HTML omitted -->@æ­£å®—æ¯’å¥¶è‡<!-- raw HTML omitted -->:â€‚é‡å‘ã€‚ <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/3825863518/OoStlxPmK">æ¨‚ [å›¾ç‰‡]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-07-23</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-3825863518-oostlxpmk/">
    
    
    
    
    
      
    
    æ¨‚ <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/3825863518/OoTsAhhQZ">é¾™å“¥ï¼šåˆ°å¤´æ¥è¿˜å¾—é æˆ‘</a></h1>
  <div class="date-author">
    
    <span class="date">2024-07-23</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-3825863518-ootsahhqz/">
    
    
    
    
    
      
    
    é¾™å“¥ï¼šåˆ°å¤´æ¥è¿˜å¾—é æˆ‘  &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/3825863518/OoTuLBf7y">è¿™æ˜¯åŒä¸€ç›˜æ£‹ã€‚[å“†å•¦Aæ¢¦å®³æ€•] [å›¾ç‰‡][å›¾ç‰‡]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-07-23</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-3825863518-ootulbf7y/">
    
    
    
    
    
      
    
    è¿™æ˜¯åŒä¸€ç›˜æ£‹ã€‚<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/3825863518/OoTWIqzh7">ç½—è€å¸ˆå¸ƒé˜µæ™ºæ…§å¤©ä¸‹ç¬¬ä¸€[è€å¸ˆå¥½]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-07-23</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-3825863518-ootwiqzh7/">
    
    
    
    
    
      
    
    ç½—è€å¸ˆå¸ƒé˜µæ™ºæ…§å¤©ä¸‹ç¬¬ä¸€<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->  &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/3825863518/OoTwNdAUn">ï¼Ÿ//@å¼ˆå®¢å›´æ£‹:ä¸»æ¬¡å¿…èƒœæ³•ï¼šå†é€ä¸€é¾™ï¼Ÿé»‘æ£‹ä¸å¤ªåƒæ´»æ£‹ï¼Œå°±ç®—æ˜¯æ´»æ£‹ï¼Œä¹Ÿè¾“ä¸çŸ¥é“å¤šå°‘ã€‚è®¤è¾“äº†ï¼Œå¼€å§‹å¤ç›˜äº†ã€‚è¿™ç›˜æ£‹æŸ¯æ´ä¸‹å¾—éå¸¸è‡­ï¼Œæå…¶ä¸å‘æŒ¥ã€‚ - è½¬å‘ @å¼ˆå®¢å›´...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-07-23</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-3825863518-ootwndaun/">
    
    
    
    
    
      
    
    ï¼Ÿ//<!-- raw HTML omitted -->@å¼ˆå®¢å›´æ£‹<!-- raw HTML omitted -->:ä¸»æ¬¡å¿…èƒœæ³•ï¼šå†é€ä¸€é¾™ï¼Ÿé»‘æ£‹ä¸å¤ªåƒæ´»æ£‹ï¼Œå°±ç®—æ˜¯æ´»æ£‹ï¼Œä¹Ÿè¾“ä¸çŸ¥é“å¤šå°‘ã€‚è®¤è¾“äº†ï¼Œå¼€å§‹å¤ç›˜äº†ã€‚è¿™ç›˜æ£‹æŸ¯æ´ä¸‹å¾—éå¸¸è‡­ï¼Œæå…¶ä¸å‘æŒ¥ã€‚<!-- raw HTML omitted --><!-- raw HTML omitted --> - è½¬å‘ <!-- raw HTML omitted -->@å¼ˆå®¢å›´æ£‹<!-- raw HTML omitted -->:â€‚è‹æ³Šå°”æ­å·é˜Ÿ VS æ·±åœ³é¾™åé˜Ÿï¼ˆæ­å·æ™ºåŠ›å¤§å¦ï¼‰<!-- raw HTML omitted -->ä¸€å°: æé’¦è¯švsæœ´å»·æ¡“(å¿«æ£‹)ï¼ˆâ€å¯é‡é¼ è®²è§£ï¼‰<!-- raw HTML omitted -->äºŒå°: ç”³çœŸè°vsæŸ¯æ´ï¼ˆä¸»æ¬¡å¿…èƒœæ³•è®²è§£ï¼‰<!-- raw HTML omitted -->ä¸‰å°: è¿ç¬‘vsé™¶æ¬£ç„¶<!-- raw HTML omitted -->å››å°: è°¢ç§‘vsæ—¶è¶Š <!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;img style=&ldquo;width: 1rem;height: 1rem&rdquo; &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/3825863518/OoTyx9jLF">æ˜å¤©å†™ï¼šèµ°è¿›KEå­¦â€”â€”æ²¡å¤´è„‘ä¸ä¸é«˜å…´[æ€’][æ€’][æ€’]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-07-23</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-3825863518-ootyx9jlf/">
    
    
    
    
    
      
    
    æ˜å¤©å†™ï¼š<!-- raw HTML omitted -->èµ°è¿›KEå­¦â€”â€”æ²¡å¤´è„‘ä¸ä¸é«˜å…´<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->  &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/6015489225/OoWOxFzmH">ä¹…ä¿å²ç»ªé‡Œ#ä¹…ä¿å²ç»ªé‡Œæ‰‹æœºåš# 2024.07.21 21:19ã€Œè°¢è°¢ã€å¤§é˜ªå…¬æ¼”çš„ä¸¤å¤©ï¼ŒçœŸçš„æ„Ÿè°¢å¤§å®¶ã€‚çœŸçš„æˆä¸ºäº†ç¾å¥½çš„æ—¶å…‰å‘¢ã€‚ã€‚æˆ‘çœŸçš„å¾ˆå–œæ¬¢è¿™æ ·æ¸æ¸ç§¯ç´¯çš„å¤å·¡ã€‚è™½ç„¶è¿˜åª...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-07-23</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-6015489225-oowoxfzmh/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->ä¹…ä¿å²ç»ªé‡Œ<!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;a href=&ldquo;<a href="https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D10%26q%3D%23%E4%B9%85%E4%BF%9D%E5%8F%B2%E7%BB%AA%E9%87%8C%E6%89%258">https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D10%26q%3D%23%E4%B9%85%E4%BF%9D%E5%8F%B2%E7%BB%AA%E9%87%8C%E6%89%8</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/6015489225/OoWZZi4QE">ä¹…ä¿å²ç»ªé‡Œ#shiorigram# å¤§é˜ªè¿™2å¤©ï¼ŒçœŸçš„æ„Ÿè°¢å¤§å®¶ã€‚ä»Šå¹´å·¡æ¼”çš„ç¬¬ä¸€ä¸ªåœ°æ–¹ã€‚å¸¦ç€ç´§å¼ æ„Ÿæ‹‰å¼€çš„åºå¹•ï¼Œå› ä¸ºæ˜¯è·Ÿå„ä½ä¸€èµ·ï¼Œæ‰€ä»¥çœŸçš„æˆä¸ºäº†ç¾å¥½çš„æ—¶å…‰ã€‚ä¹‹åæ˜¯çˆ±çŸ¥ã€‚æ˜¯...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-07-23</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-6015489225-oowzzi4qe/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->ä¹…ä¿å²ç»ªé‡Œ<!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;a href=&ldquo;<a href="https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D10%26q%3D%23shiorigram%23&amp;amp;extparam=%23shiorigra">https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D10%26q%3D%23shiorigram%23&amp;amp;extparam=%23shiorigra</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/6015489225/OoX0550nT">ä¹…ä¿å²ç»ªé‡Œ#ä¹…ä¿å²ç»ªé‡Œæ‰‹æœºåš# 2024.07.22 20:52ã€Œå“¦å“Ÿå“Ÿã€æ—©ä¸Šå¥½çœŸçš„åŠªåŠ›äº†å§è¿™ä¸ªæ—©ä¸Šæ„Ÿè§‰åˆ°ç•™ä¸‹äº†åŠªåŠ›çš„è¯æ®å‘¢å°†è¿™ç§°ä¸ºå¹¸ç¦å§ç¡å¾—å¾ˆæ²‰ã€‚ã€‚ä»Šå¤©ä¹Ÿè¦åŠªåŠ›å–½è¦ç...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-07-23</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-6015489225-oox0550nt/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->ä¹…ä¿å²ç»ªé‡Œ<!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;a href=&ldquo;<a href="https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D10%26q%3D%23%E4%B9%85%E4%BF%9D%E5%8F%B2%E7%BB%AA%E9%87%8C%E6%89%8B%E6%9C%BA%E5%8D%9A%23">https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D10%26q%3D%23%E4%B9%85%E4%BF%9D%E5%8F%B2%E7%BB%AA%E9%87%8C%E6%89%8B%E6%9C%BA%E5%8D%9A%23</a>&amp; &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/6015489225/OoX0ew9QB">ä¹…ä¿å²ç»ªé‡Œ#ä¹…ä¿å²ç»ªé‡Œæ‰‹æœºåš# 2024.07.22 20:54ã€Œæ¬¸å˜¿ã€æ€¥å¿™â€å“‡ï½â€œåœ°æ‹çš„ç…§ç‰‡â˜ºï¸ [å›¾ç‰‡]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-07-23</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-6015489225-oox0ew9qb/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->ä¹…ä¿å²ç»ªé‡Œ<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;span &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/6015489225/OoX0m1ajW">ä¹…ä¿å²ç»ªé‡Œ#ä¹…ä¿å²ç»ªé‡Œæ‰‹æœºåš# 2024.07.23 17:22ã€Œå‘µå‘µã€å‘œå“‡å•Šä»Šå¤©å¥½çƒ­å‘¢è¯·ä¸è¦å‹‰å¼ºå‘¢ã€‚æˆ‘ä¹Ÿåœ¨åŠªåŠ›ï¼ï¼ï¼å°±ç®—æ˜¯æƒ…ç»ªä½è½çš„æ—¶å€™ä¹Ÿè¦è‡ªå·±è®¾æ³•è®©å†…å¿ƒæŒ¯ä½œèµ·æ¥ã€‚è™½...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-07-23</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-6015489225-oox0m1ajw/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->ä¹…ä¿å²ç»ªé‡Œ<!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;a href=&ldquo;<a href="https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D10%26q%3D%23%E4%B9%85%E4">https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D10%26q%3D%23%E4%B9%85%E4</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/7332621109/OoUi3Enzg">æŸ¯æ´#2024ä¹å±…ä¹æ¯ä¸­å›½å›´æ£‹ç”²çº§è”èµ›# #èµ›æœå‘å¸ƒ# æœ´å»·æ¡“èƒœæé’¦è¯šï¼ŒæŸ¯æ´è´Ÿç”³çœŸè°ï¼Œé™¶æ¬£ç„¶èƒœè¿ç¬‘ï¼Œæ—¶è¶Šèƒœè°¢ç§‘ï¼Œæ·±åœ³é¾™åé˜Ÿ3æ¯”1èƒœè‹æ³Šå°”æ­å·é˜Ÿã€‚æ­å–œæˆ‘ä»¬æ·±åœ³é¾™åé˜Ÿ...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-07-23</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-7332621109-ooui3enzg/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->æŸ¯æ´<!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;a href=&ldquo;<a href="https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D10%26q%3D%232024%E4%B9%90%E5%B1%85%E4%B9%90%E6%9D%AF%E4%B8%AD%E5%9B%BD%E5%9B%B4%E6%A3%8B%E7%94%B2%E7%BA%A7%E8%81%94%E8%B5%9B%23&amp;amp;extparam=%232024%E4%25B">https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D10%26q%3D%232024%E4%B9%90%E5%B1%85%E4%B9%90%E6%9D%AF%E4%B8%AD%E5%9B%BD%E5%9B%B4%E6%A3%8B%E7%94%B2%E7%BA%A7%E8%81%94%E8%B5%9B%23&amp;amp;extparam=%232024%E4%B</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/7332621109/OoVt6kYTg">æŸ¯æ´#2024ä¹å±…ä¹æ¯ä¸­å›½å›´æ£‹ç”²çº§è”èµ›# - è½¬å‘ @Sketchy_shellice:&amp;ensp;å¼€åœºè±¹ï¼ˆ2ï¼‰ [å›¾ç‰‡][å›¾ç‰‡][å›¾ç‰‡][å›¾ç‰‡][å›¾ç‰‡][å›¾ç‰‡][å›¾ç‰‡][å›¾ç‰‡][å›¾ç‰‡]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-07-23</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-7332621109-oovt6kytg/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->æŸ¯æ´<!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;a href=&ldquo;<a href="https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D10%26q%3D%232024%E4%B9%90%E5%B1%85%E4%B9%90%E6%9D%AF%E4%B8%AD%E5%9B%BD%E5%9B%B4%E6%A3%8B%E7%94%B2%E7%BA%A7%E8%81%94%E8%B5%9B%23&amp;amp;extparam=%232024%E4%B9%90%E5%B1%85%E4">https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D10%26q%3D%232024%E4%B9%90%E5%B1%85%E4%B9%90%E6%9D%AF%E4%B8%AD%E5%9B%BD%E5%9B%B4%E6%A3%8B%E7%94%B2%E7%BA%A7%E8%81%94%E8%B5%9B%23&amp;amp;extparam=%232024%E4%B9%90%E5%B1%85%E4</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/7332621109/OoVt9scda">æŸ¯æ´#2024ä¹å±…ä¹æ¯ä¸­å›½å›´æ£‹ç”²çº§è”èµ›# - è½¬å‘ @Sketchy_shellice:&amp;ensp;è¿™ä¸ªè±¹æŠ¿å˜´ç©å°±æ¸…æ™°å¤šå•¦[é€èŠ±èŠ±] Sketchy_shelliceçš„å¾®åšè§†é¢‘</a></h1>
  <div class="date-author">
    
    <span class="date">2024-07-23</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-7332621109-oovt9scda/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->æŸ¯æ´<!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;a href=&ldquo;<a href="https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D10%26q%3D%232024%E4%B9%90%E5%B1%85%E4%B9%90%E6%9D%AF%E4%B8%AD%E5%9B%BD%E5%9B%B4%E6%A3%8B%E7%94%B2%E7%BA%A7%E8%81%94%E8%B5%9B%23&amp;amp;extparam=%232024%E4%B9%90%E5%B1">https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D10%26q%3D%232024%E4%B9%90%E5%B1%85%E4%B9%90%E6%9D%AF%E4%B8%AD%E5%9B%BD%E5%9B%B4%E6%A3%8B%E7%94%B2%E7%BA%A7%E8%81%94%E8%B5%9B%23&amp;amp;extparam=%232024%E4%B9%90%E5%B1</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/7332621109/OoVtetA8S">æŸ¯æ´#2024ä¹å±…ä¹æ¯ä¸­å›½å›´æ£‹ç”²çº§è”èµ›# - è½¬å‘ @Sketchy_shellice:&amp;ensp;ä¸€ä¸ªå•ƒçˆªçˆªä¸€ä¸ªé¼“è…®å¸®ï¼Œå…¨éƒ½éœ²å‡ºæœ¬ä½“å•¦[ç¾å—’å—’] Sketchy_shelliceçš„å¾®åšè§†é¢‘</a></h1>
  <div class="date-author">
    
    <span class="date">2024-07-23</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-7332621109-oovteta8s/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->æŸ¯æ´<!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;a href=&ldquo;<a href="https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D10%26q%3D%232024%E4%B9%90%E5%B1%85%E4%B9%90%E6%9D%AF%E4%B8%AD%E5%9B%BD%E5%9B%B4%E6%A3%8B%E7%94%B2%E7%BA%A7%E8%81%94%E8%B5%9B%23&amp;amp;extparam=%232024%E4%B9%90%E5%25">https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D10%26q%3D%232024%E4%B9%90%E5%B1%85%E4%B9%90%E6%9D%AF%E4%B8%AD%E5%9B%BD%E5%9B%B4%E6%A3%8B%E7%94%B2%E7%BA%A7%E8%81%94%E8%B5%9B%23&amp;amp;extparam=%232024%E4%B9%90%E5%</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/7332621109/OoVth9iRm">æŸ¯æ´#2024ä¹å±…ä¹æ¯ä¸­å›½å›´æ£‹ç”²çº§è”èµ›# - è½¬å‘ @Sketchy_shellice:&amp;ensp;å…¥åœº&amp;å¼€åœºè±¹ï¼ˆ1ï¼‰å¥½å¯çˆ±å¥½ä¹–å–”[å¯æ€œ] [å›¾ç‰‡][å›¾ç‰‡][å›¾ç‰‡][å›¾ç‰‡][å›¾ç‰‡][å›¾ç‰‡][å›¾ç‰‡][å›¾ç‰‡][...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-07-23</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-7332621109-oovth9irm/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->æŸ¯æ´<!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;a href=&ldquo;<a href="https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D10%26q%3D%232024%E4%B9%90%E5%B1%85%E4%B9%90%E6%9D%AF%E4%B8%AD%E5%9B%BD%E5%9B%B4%E6%A3%8B%E7%94%B2%E7%BA%A7%E8%81%94%E8%B5%9B%23&amp;amp;extparam=%232024%E4%B9%90%E5%B1%85%25">https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D10%26q%3D%232024%E4%B9%90%E5%B1%85%E4%B9%90%E6%9D%AF%E4%B8%AD%E5%9B%BD%E5%9B%B4%E6%A3%8B%E7%94%B2%E7%BA%A7%E8%81%94%E8%B5%9B%23&amp;amp;extparam=%232024%E4%B9%90%E5%B1%85%</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/7332621109/OoZxGh1UX">æŸ¯æ´#2024ä¹å±…ä¹æ¯ä¸­å›½å›´æ£‹ç”²çº§è”èµ›# - è½¬å‘ @_é™½æ¤¿ç¨»ç¬˜_:&amp;ensp;æŸ¯æ´ ä»Šå¤©çš„ä¹å®«æ ¼è±¹è±¹[ç¾å—’å—’][ç¾å—’å—’] [å›¾ç‰‡][å›¾ç‰‡][å›¾ç‰‡][å›¾ç‰‡][å›¾ç‰‡][å›¾ç‰‡][å›¾ç‰‡][å›¾ç‰‡][å›¾...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-07-23</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-7332621109-oozxgh1ux/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->æŸ¯æ´<!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;a href=&ldquo;<a href="https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D10%26q%3D%232024%E4%B9%90%E5%B1%85%E4%B9%90%E6%9D%AF%E4%B8%AD%E5%9B%BD%E5%9B%B4%E6%A3%8B%E7%94%B2%E7%BA%A7%E8%81%94%E8%B5%9B%23&amp;amp;extparam=%232024%E4%B9%90%E5%B1%85%25E">https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D10%26q%3D%232024%E4%B9%90%E5%B1%85%E4%B9%90%E6%9D%AF%E4%B8%AD%E5%9B%BD%E5%9B%B4%E6%A3%8B%E7%94%B2%E7%BA%A7%E8%81%94%E8%B5%9B%23&amp;amp;extparam=%232024%E4%B9%90%E5%B1%85%E</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/7332621109/OoZxKpbq0">æŸ¯æ´#2024ä¹å±…ä¹æ¯ä¸­å›½å›´æ£‹ç”²çº§è”èµ›# - è½¬å‘ @æ²è¨€è¨€_:&amp;ensp;æŸ¯æ´æŠŠä»Šå¤©æ‹çš„éƒ½å‘è¶…è¯é‡Œå•¦ [å›¾ç‰‡][å›¾ç‰‡][å›¾ç‰‡][å›¾ç‰‡][å›¾ç‰‡][å›¾ç‰‡][å›¾ç‰‡][å›¾ç‰‡][å›¾ç‰‡]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-07-23</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-7332621109-oozxkpbq0/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->æŸ¯æ´<!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;a href=&ldquo;<a href="https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D10%26q%3D%232024%E4%B9%90%E5%B1%85%E4%B9%90%E6%9D%AF%E4%B8%AD%E5%9B%BD%E5%9B%B4%E6%A3%8B%E7%94%B2%E7%BA%A7%E8%81%94%E8%B5%9B%23&amp;amp;extparam=%232024%E4%B9%90%E5%B1%85%25">https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D10%26q%3D%232024%E4%B9%90%E5%B1%85%E4%B9%90%E6%9D%AF%E4%B8%AD%E5%9B%BD%E5%9B%B4%E6%A3%8B%E7%94%B2%E7%BA%A7%E8%81%94%E8%B5%9B%23&amp;amp;extparam=%232024%E4%B9%90%E5%B1%85%</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/7332621109/OoZxNi5Ty">æŸ¯æ´#2024ä¹å±…ä¹æ¯ä¸­å›½å›´æ£‹ç”²çº§è”èµ›# - è½¬å‘ @æ²è¨€è¨€_:&amp;ensp;ä»Šæ—¥ğŸ†ï¼ˆ2ï¼‰æŸ¯æ´ [å›¾ç‰‡][å›¾ç‰‡][å›¾ç‰‡][å›¾ç‰‡][å›¾ç‰‡][å›¾ç‰‡][å›¾ç‰‡][å›¾ç‰‡][å›¾ç‰‡]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-07-23</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-7332621109-oozxni5ty/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->æŸ¯æ´<!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;a href=&ldquo;<a href="https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D10%26q%3D%232024%E4%B9%90%E5%B1%85%E4%B9%90%E6%9D%AF%E4%B8%AD%E5%9B%BD%E5%9B%B4%E6%A3%8B%E7%94%B2%E7%BA%A7%E8%81%94%E8%B5%9B%23&amp;amp;extparam=%232024%E4%B9%90%E5%B1%85%E4">https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D10%26q%3D%232024%E4%B9%90%E5%B1%85%E4%B9%90%E6%9D%AF%E4%B8%AD%E5%9B%BD%E5%9B%B4%E6%A3%8B%E7%94%B2%E7%BA%A7%E8%81%94%E8%B5%9B%23&amp;amp;extparam=%232024%E4%B9%90%E5%B1%85%E4</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/7332621109/OoZxQ00JZ">æŸ¯æ´#2024ä¹å±…ä¹æ¯ä¸­å›½å›´æ£‹ç”²çº§è”èµ›# - è½¬å‘ @æ²è¨€è¨€_:&amp;ensp;ä»Šæ—¥å›¾é›†3æŸ¯æ´ [å›¾ç‰‡][å›¾ç‰‡][å›¾ç‰‡][å›¾ç‰‡][å›¾ç‰‡][å›¾ç‰‡][å›¾ç‰‡][å›¾ç‰‡][å›¾ç‰‡]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-07-23</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-7332621109-oozxq00jz/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->æŸ¯æ´<!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;a href=&ldquo;<a href="https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D10%26q%3D%232024%E4%B9%90%E5%B1%85%E4%B9%90%E6%9D%AF%E4%B8%AD%E5%9B%BD%E5%9B%B4%E6%A3%8B%E7%94%B2%E7%BA%A7%E8%81%94%E8%B5%9B%23&amp;amp;extparam=%232024%E4%B9%90%E5%B1%85%E4">https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D10%26q%3D%232024%E4%B9%90%E5%B1%85%E4%B9%90%E6%9D%AF%E4%B8%AD%E5%9B%BD%E5%9B%B4%E6%A3%8B%E7%94%B2%E7%BA%A7%E8%81%94%E8%B5%9B%23&amp;amp;extparam=%232024%E4%B9%90%E5%B1%85%E4</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://www.bilibili.com/video/BV11S411w7WV">æŸ¯æ´æœ€æƒ¨å±€ï¼šä¸­ä½çº§é£åˆ€ï¼Œé­åç”Ÿæ¯’æ‰“ï¼Œæ­»å¤šæ¡å¤§é¾™ï¼Œç»“å…«è´¥ä¹‹äº¤ï¼</a></h1>
  <div class="date-author">
    
    <span class="date">2024-07-23</span>
  </div>
  <div class="summary">
    <a href="/post/www-bilibili-com-video-bv11s411w7wv/">
    
    
    
    
    
      
    
    æŸ¯æ´æœ€æƒ¨å±€ï¼šä¸­ä½çº§é£åˆ€ï¼Œé­åç”Ÿæ¯’æ‰“ï¼Œæ­»å¤šæ¡å¤§é¾™ï¼Œç»“å…«è´¥ä¹‹äº¤ï¼<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://www.bilibili.com/video/BV134421S7x3">å¥³äººå’Œç”µè„‘ï¼Œä½ æ€ä¹ˆé€‰ï¼Ÿ</a></h1>
  <div class="date-author">
    
    <span class="date">2024-07-23</span>
  </div>
  <div class="summary">
    <a href="/post/www-bilibili-com-video-bv134421s7x3/">
    
    
    
    
    
      
    
    -<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://www.bilibili.com/video/BV15U411S7gp">é™ˆç¿”å…­ç‚¹åŠï¼šå®¶äº§ä¿å«æˆ˜</a></h1>
  <div class="date-author">
    
    <span class="date">2024-07-23</span>
  </div>
  <div class="summary">
    <a href="/post/www-bilibili-com-video-bv15u411s7gp/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://www.bilibili.com/video/BV1Ff421i7Ef">ç»™å¤§å®¶ç§ç§ç¼…å› çŠ¬æœ‰å¤šåƒåŠ²å„¿~</a></h1>
  <div class="date-author">
    
    <span class="date">2024-07-23</span>
  </div>
  <div class="summary">
    <a href="/post/www-bilibili-com-video-bv1ff421i7ef/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://www.bilibili.com/video/BV1kw4m1k7vK">å‡å¦‚æ¨¡ä»¿å¼ éŸ¶æ¶µçš„å‘³é“å”± ï¼Œâ€œç¥å•Šï¼å¯ä¸å¯ä»¥è®©æˆ‘æ„Ÿå—ä¸€ä¸‹ï¼Ÿâ€</a></h1>
  <div class="date-author">
    
    <span class="date">2024-07-23</span>
  </div>
  <div class="summary">
    <a href="/post/www-bilibili-com-video-bv1kw4m1k7vk/">
    
    
    
    
    
      
    
    ã€Šæš®è‰²å›å“ã€‹
åŸå”±ï¼šå‰æ˜Ÿå‡ºç§Ÿ
ç‰ˆæœ¬ï¼šå¼ éŸ¶æ¶µ
æ¼”å”±ï¼šå’»å’»æ»¡
æ ¡å¯¹ï¼šè‰¾è‰Anicca
æ··éŸ³ï¼šæ´‹è‘±æ··éŸ³å·¥ä½œå®¤<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://www.bilibili.com/video/BV1Kz421i7me">è¿™æ˜¯æˆ‘çš„æ¢¦ä¸­æƒ…ç‹—å‘€ï¼Œé›ªç™½çš„æ¯›å‘ä¿Šä¿çš„è„¸åºï¼Œè¿™æ ·çš„åœŸæ¾ç»™æˆ‘æ¥ä¸€æ‰“â€¦â€¦</a></h1>
  <div class="date-author">
    
    <span class="date">2024-07-23</span>
  </div>
  <div class="summary">
    <a href="/post/www-bilibili-com-video-bv1kz421i7me/">
    
    
    
    
    
      
    
    è¿™æ˜¯æˆ‘çš„æ¢¦ä¸­æƒ…ç‹—å‘€ï¼Œé›ªç™½çš„æ¯›å‘ä¿Šä¿çš„è„¸åºï¼Œè¿™æ ·çš„åœŸæ¾ç»™æˆ‘æ¥ä¸€æ‰“â€¦â€¦<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://www.bilibili.com/video/BV1oy411e7F5">æ°‘è¿›å…šè¯‹æ¯å¤§é™†åˆ©ç”¨ç¥æ˜ç»Ÿæˆ˜ï¼Œä»æŒ¡ä¸ä½28ä¸‡å°æ¹¾äººæ¬²èµ´å¤§é™†æ—…æ¸¸ï¼</a></h1>
  <div class="date-author">
    
    <span class="date">2024-07-23</span>
  </div>
  <div class="summary">
    <a href="/post/www-bilibili-com-video-bv1oy411e7f5/">
    
    
    
    
    
      
    
    è¿ç¥æ˜éƒ½èƒ½è¯´æˆæ˜¯ç»Ÿæˆ˜å·¥å…·? æ°‘è¿›å…šåƒæ–¹ç™¾è®¡é˜»æ­¢å°æ¹¾äººåˆ°å¤§é™†æ—…æ¸¸æ— æ•ˆ!<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://www.bilibili.com/video/BV1Z4421Z7Vn">è½¦åˆ®äº†ï¼Œå…³æ±¤å§†çŒ«ä»€ä¹ˆäº‹ï¼Ÿ</a></h1>
  <div class="date-author">
    
    <span class="date">2024-07-23</span>
  </div>
  <div class="summary">
    <a href="/post/www-bilibili-com-video-bv1z4421z7vn/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://www.zhihu.com/question/661673450/answer/3570852291">é‡å­ä½å›ç­”äº†é—®é¢˜: Meta Llama 3 è¢«æ› 7 æœˆ 23 æ—¥å‘å¸ƒï¼Œè¯¥æ¨¡å‹æœ‰å“ªäº›æ–°çš„ç‰¹æ€§å’ŒåŠŸèƒ½ï¼Ÿ</a></h1>
  <div class="date-author">
    
    <span class="date">2024-07-23</span>
  </div>
  <div class="summary">
    <a href="/post/www-zhihu-com-question-661673450-answer-3570852291/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted -->
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://zhuanlan.zhihu.com/p/671472916">é‡å­ä½èµåŒäº†æ–‡ç« : å‹ç¼©å³æ™ºèƒ½ ï¼ˆcompression for AIï¼‰éšç¬”</a></h1>
  <div class="date-author">
    
    <span class="date">2024-07-23</span>
  </div>
  <div class="summary">
    <a href="/post/zhuanlan-zhihu-com-p-671472916/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted -->
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://zhuanlan.zhihu.com/p/710390129">é‡å­ä½å‘è¡¨äº†æ–‡ç« : å¼€æºç•Œæœ‰äº†æœ€å¼ºå¤§æ¨¡å‹ï¼šLlama 3.1æ›å…‰è·‘åˆ†è¶…GPT-4oï¼Œä¸‹è½½é“¾æ¥å·²æ³„éœ²</a></h1>
  <div class="date-author">
    
    <span class="date">2024-07-23</span>
  </div>
  <div class="summary">
    <a href="/post/zhuanlan-zhihu-com-p-710390129/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted -->
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://zhuanlan.zhihu.com/p/710499265">é‡å­ä½å‘è¡¨äº†æ–‡ç« : å‡ ä½•æœ—å…°å…¹çŒœæƒ³è¢«è§£å†³ï¼å†æ—¶30å¹´ã€è¯æ˜è®ºæ–‡è¾¾800ä½™é¡µï¼Œä¸­å›½å­¦è€…é™ˆéºŸç³»ä¸»è¦ä½œè€…</a></h1>
  <div class="date-author">
    
    <span class="date">2024-07-23</span>
  </div>
  <div class="summary">
    <a href="/post/zhuanlan-zhihu-com-p-710499265/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted -->
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://zhuanlan.zhihu.com/p/710504483">é‡å­ä½å‘è¡¨äº†æ–‡ç« : å¿«æ‰‹å¯çµå›¢é˜Ÿæœ€æ–°å¼€æºé¡¹ç›®ç«äº†ï¼šå¤§å”å®æ—¶å˜èº«å°‘å¥³ï¼ŒGitHubç‹‚æ½7.5Kæ˜Ÿ</a></h1>
  <div class="date-author">
    
    <span class="date">2024-07-23</span>
  </div>
  <div class="summary">
    <a href="/post/zhuanlan-zhihu-com-p-710504483/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted -->
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://zhuanlan.zhihu.com/p/710518657">é‡å­ä½å‘è¡¨äº†æ–‡ç« : é©¬æ–¯å…‹ç‹‚æ½10ä¸‡å—H100ï¼Œè‡ªå»ºä¸–ç•Œæœ€å¼ºAIè¶…ç®—ï¼Œä¸‹ä¸€ä»£æ¨¡å‹è®­ç»ƒå¼€å§‹</a></h1>
  <div class="date-author">
    
    <span class="date">2024-07-23</span>
  </div>
  <div class="summary">
    <a href="/post/zhuanlan-zhihu-com-p-710518657/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted -->
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://zhuanlan.zhihu.com/p/710523358">é‡å­ä½å‘è¡¨äº†æ–‡ç« : è‹±ç‰¹å°”CPUç–¯ç‹‚å´©æºƒï¼Œæµ‹è¯„å¤§ä½¬æ­éœ²å·¥è‰ºç¼ºé™·ï¼Œå®˜æ–¹å›åº”ï¼šä¿®å¤è¡¥ä¸ä¸‹æœˆä¸Šçº¿</a></h1>
  <div class="date-author">
    
    <span class="date">2024-07-23</span>
  </div>
  <div class="summary">
    <a href="/post/zhuanlan-zhihu-com-p-710523358/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted -->
    </a>
  </div>
</section>

</main>
</div>

<script async src="//yihui.name/js/center-img.js"></script>

<footer>

<div class="footer">
  <ul class="menu">
    
    <li><a href="/"><span data-hover="Home">Home</span></a></li>
    
    <li><a href="/about/"><span data-hover="About">About</span></a></li>
    
    <li><a href="/archives/"><span data-hover="Archive">Archive</span></a></li>
    
    <li><a href="/contributor/"><span data-hover="Contributor">Contributor</span></a></li>
    
    <li><a href="/index.xml"><span data-hover="Subscribe">Subscribe</span></a></li>
    
  </ul>
  
  <div class="copyright">Â© <a href="https://rainoffallingstar.github.io">Fallingstar</a> 2023 | <a href="https://github.com/rainoffallingstar">Github</a></div>
  
</div>
</footer>







</body>
</html>

